https://info.adarepharmasolutions.com/resources/multiparticulates-transforming-oral-therapies-through-patient-centric-designhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Multiparticulates%20Transforming%20Oral%20Therapies%20Through%20Patient-Centric%20Design.mp4/medium.jpgMultiparticulates: Transforming Oral Therapies Through Patient-Centric DesignMultiparticulates Transforming Oral Therapies Through Patient-Centric Designhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Multiparticulates%20Transforming%20Oral%20Therapies%20Through%20Patient-Centric%20Design.mp43303nonoMultiParticulatesDoseFlexibilityPharmaceuticalInnovationOralDrugDeliveryPatientCentricityhttps://info.adarepharmasolutions.com/hubfs/Right%20the%20First%20Time%20in%202026%20Modern%20Strategies%20to%20De-Risk%20Complex%20Oral%20Programs%20Under%20Capital%20Pressure%20(1).pngRight the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)Right the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/The%20Future%20of%20Pharma%20Packaging_%20Trends%2c%20Technologies%2c%20and%20Patient-Centric%20Solutions.pngThe Future of Pharma Packaging_ Trends, Technologies, and Patient-Centric SolutionsThe Future of Pharma Packaging_ Trends, Technologies, and Patient-Centric Solutionshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/Multiparticulates_%20Transforming%20Oral%20Therapies%20Through%20Patient-Centric%20Design.pngMultiparticulates_ Transforming Oral Therapies Through Patient-Centric DesignMultiparticulates_ Transforming Oral Therapies Through Patient-Centric Designhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Webinar%20Your%20Partner%20for%20OSD%20Success%20Thumbnail-1.jpgWebinar Your Partner for OSD Success Thumbnail-1Webinar Your Partner for OSD Success Thumbnail-12026-03-30https://info.adarepharmasolutions.com/resources/pessano-facility-tourhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Pessano%20Facility%20Tour.mp4/medium.jpgAdare Pharma Solutions Pessano Facility TourPessano Facility Tourhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Pessano%20Facility%20Tour.mp4304nonoAdarePharmaSolutionsPessanoFacilityLaboratoryProcess3DPrintingCapabilitiesPharmaceuticalTechnologyhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/resources/advances-in-oral-glp-1-analogs-for-obesity-market-insights-challenges-and-delivery-strategieshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Advances%20in%20Oral%20GLP-1%20Analogs%20for%20Obesity%20Market%20Insights%2c%20Challenges%2c%20and%20Delivery%20Strategies.mp4/medium.jpgAdvances in Oral GLP-1 Analogs for Obesity: Market Insights, Challenges, and Delivery StrategiesAdvances in Oral GLP-1 Analogs for Obesity Market Insights, Challenges, and Delivery Strategieshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Advances%20in%20Oral%20GLP-1%20Analogs%20for%20Obesity%20Market%20Insights%2c%20Challenges%2c%20and%20Delivery%20Strategies.mp43648nonoOralGLP1AnalogsMarketInsightsObesityTreatmentPharmaceuticalAdvancementsDrugDeliveryStrategieshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/Multiparticulates_%20Transforming%20Oral%20Therapies%20Through%20Patient-Centric%20Design.pngMultiparticulates_ Transforming Oral Therapies Through Patient-Centric DesignMultiparticulates_ Transforming Oral Therapies Through Patient-Centric Designhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/Advances%20in%20Oral%20GLP-1%20Analogs%20for%20Obesity_%20Market%20Insights%2c%20Challenges%2c%20and%20Delivery%20Strategies.pngAdvances in Oral GLP-1 Analogs for Obesity_ Market Insights, Challenges, and Delivery StrategiesAdvances in Oral GLP-1 Analogs for Obesity_ Market Insights, Challenges, and Delivery Strategieshttps://info.adarepharmasolutions.com/hubfs/Right%20the%20First%20Time%20in%202026%20Modern%20Strategies%20to%20De-Risk%20Complex%20Oral%20Programs%20Under%20Capital%20Pressure%20(1).pngRight the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)Right the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)https://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Webinar%20Your%20Partner%20for%20OSD%20Success%20Thumbnail-1.jpgWebinar Your Partner for OSD Success Thumbnail-1Webinar Your Partner for OSD Success Thumbnail-12026-03-30https://info.adarepharmasolutions.com/resources/pharmaceutical-3d-screen-printing-breakthrough-solutions-for-patient-centric-therapies-2https://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partnerhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Speaker%20Presentations/Pharmaceutical%203D%20Screen%20Printing_%20Breakthrough%20Solutions%20for%20Patient-Centric%20Therapies.pngPharmaceutical 3D Screen Printing_ Breakthrough Solutions for Patient-Centric TherapiesPharmaceutical 3D Screen Printing_ Breakthrough Solutions for Patient-Centric Therapies2026-03-30https://info.adarepharmasolutions.com/newsroomhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/NEWS-Main.webpNEWS-MainNEWS-Main2026-05-06https://info.adarepharmasolutions.com/resources/aaps-development-of-age-appropriate-patient-centric-easy-to-swallow-novel-dosage-form-for-dysphagia-and-special-patient-populationshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Blog%20Thumbnails/AAPS-presentation-cover.webpAAPS-presentation-coverAAPS-presentation-coverhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partner2026-03-24https://info.adarepharmasolutions.com/resources/layer-by-layer-3d-screen-printing-and-the-future-of-drug-developmenthttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/Layer%20by%20Layer%203D%20Screen%20Printing%20and%20the%20Future%20of%20Drug%20Development-1.pngLayer by Layer 3D Screen Printing and the Future of Drug Development-1Layer by Layer 3D Screen Printing and the Future of Drug Development-1https://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partner2026-03-30https://info.adarepharmasolutions.com/resources/partnership-opportunities-in-drug-delivery-multiparticulates-a-versatile-tool-for-patient-centric-fixed-dose-combination-applicationshttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partner2026-03-24https://info.adarepharmasolutions.com/resources/optimizing-mro-procurement-with-rs-italiahttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Enhancing%20Serialization%20&%20Automation%20to%20Support%20Customer%20Success.pngEnhancing Serialization & Automation to Support Customer SuccessEnhancing Serialization & Automation to Support Customer Successhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Optimizing%20MRO%20Procurement%20with%20RS%20Italia.pngOptimizing MRO Procurement with RS ItaliaOptimizing MRO Procurement with RS Italiahttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Delivering%20a%20Critical%20Therapy%20From%20FDA%20Approval%20to%20Patients%20in%2010%20Days.pngDelivering a Critical Therapy From FDA Approval to Patients in 10 DaysDelivering a Critical Therapy From FDA Approval to Patients in 10 Dayshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Unlocking%20Higher%20Complex%20Capsule%20Yields%20Through%20More%20Efficient%20Manufacturing.pngUnlocking Higher Complex Capsule Yields Through More Efficient ManufacturingUnlocking Higher Complex Capsule Yields Through More Efficient Manufacturing2026-03-30https://info.adarepharmasolutions.com/resources/from-ambiguity-to-action-the-fdas-new-nitrosamine-guidancehttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Speaker%20Presentations/Presentation%20From%20Ambiguity%20To%20Action_%20The%20FDA%E2%80%99s%20New%20Nitrosamine%20Guidance.pngPresentation From Ambiguity To Action_ The FDA’s New Nitrosamine GuidancePresentation From Ambiguity To Action_ The FDA’s New Nitrosamine Guidancehttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partnerhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Blog%20Thumbnails/Nitrosamine-webinar-resource-center.webpNitrosamine-webinar-resource-centerNitrosamine-webinar-resource-center2026-03-24https://info.adarepharmasolutions.com/newsroom/2026/03/achieve-life-sciences-announces-partnership-with-adare-pharma-solutions-for-cytisinicline-manufacturinghttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Picture1.webpPicture1Picture12026-05-18https://info.adarepharmasolutions.com/resources/on-demand-webinar-formulation-drug-development-trendshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Formulation%20&%20Drug%20Development%20Trends.mp4/medium.jpgFormulation and Drug Development Trends: Solutions for Addressing Solubility, Bioavailability, and Stability ChallengesFormulation & Drug Development Trendshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Formulation%20&%20Drug%20Development%20Trends.mp43753nonoDrugDevelopmentSolubilityEnhancementAmorphousSolidDispersionPharmaceuticalFormulationsBioavailabilityImprovementhttps://info.adarepharmasolutions.com/hubfs/Right%20the%20First%20Time%20in%202026%20Modern%20Strategies%20to%20De-Risk%20Complex%20Oral%20Programs%20Under%20Capital%20Pressure%20(1).pngRight the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)Right the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)https://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Webinar%20Your%20Partner%20for%20OSD%20Success%20Thumbnail-1.jpgWebinar Your Partner for OSD Success Thumbnail-1Webinar Your Partner for OSD Success Thumbnail-1https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/Multiparticulates_%20Transforming%20Oral%20Therapies%20Through%20Patient-Centric%20Design.pngMultiparticulates_ Transforming Oral Therapies Through Patient-Centric DesignMultiparticulates_ Transforming Oral Therapies Through Patient-Centric Designhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/Formulation%20&%20Drug%20Development%20Trends.pngFormulation & Drug Development TrendsFormulation & Drug Development Trends2026-03-30https://info.adarepharmasolutions.com/resources/cphi-north-america-a-guide-to-successful-collaboration-considerations-when-choosing-your-first-cdmo-as-a-start-uphttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partner2026-03-24https://info.adarepharmasolutions.com/newsroom/dsm-agrees-to-terms-to-acquire-postbiotics-pioneer-adare-biomehttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-05-18https://info.adarepharmasolutions.com/resources/optimizing-pediatric-product-development-for-commercialization-successhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Optimizing%20Pediatric%20Product%20Development%20For%20Commercialization%20Success.mp4/medium.jpgOptimizing Pediatric Product Development For Commercialization SuccessOptimizing Pediatric Product Development For Commercialization Successhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Optimizing%20Pediatric%20Product%20Development%20For%20Commercialization%20Success.mp43736nonohttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/Optimizing%20Pediatric%20Product%20Development%20For%20Commercialization%20Success.pngOptimizing Pediatric Product Development For Commercialization SuccessOptimizing Pediatric Product Development For Commercialization Successhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/Multiparticulates_%20Transforming%20Oral%20Therapies%20Through%20Patient-Centric%20Design.pngMultiparticulates_ Transforming Oral Therapies Through Patient-Centric DesignMultiparticulates_ Transforming Oral Therapies Through Patient-Centric Designhttps://info.adarepharmasolutions.com/hubfs/Right%20the%20First%20Time%20in%202026%20Modern%20Strategies%20to%20De-Risk%20Complex%20Oral%20Programs%20Under%20Capital%20Pressure%20(1).pngRight the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)Right the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)https://info.adarepharmasolutions.com/hubfs/Webinar%20Your%20Partner%20for%20OSD%20Success%20Thumbnail-1.jpgWebinar Your Partner for OSD Success Thumbnail-1Webinar Your Partner for OSD Success Thumbnail-12026-03-30https://info.adarepharmasolutions.com/newsroom/adare-pharmaceuticals-inc.-acquires-orbis-bioscienceshttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-05-18https://info.adarepharmasolutions.com/resources/on-demand-webinar-patient-adherence-for-isolated-populations-during-the-pandemichttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/On-Demand%20Webinar%20Patient%20Adherence%20for%20Isolated%20Populations%20During%20the%20Pandemic.mp4/medium.jpgOn-Demand Webinar: Patient Adherence for Isolated Populations During the PandemicOn-Demand Webinar Patient Adherence for Isolated Populations During the Pandemichttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/On-Demand%20Webinar%20Patient%20Adherence%20for%20Isolated%20Populations%20During%20the%20Pandemic.mp43380nonoIsolatedPopulationsMedicationChallengesCOVIDCompliancePharmaceuticalStrategiesPatientAdherencehttps://info.adarepharmasolutions.com/hubfs/Right%20the%20First%20Time%20in%202026%20Modern%20Strategies%20to%20De-Risk%20Complex%20Oral%20Programs%20Under%20Capital%20Pressure%20(1).pngRight the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)Right the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)https://info.adarepharmasolutions.com/hubfs/Webinar%20Your%20Partner%20for%20OSD%20Success%20Thumbnail-1.jpgWebinar Your Partner for OSD Success Thumbnail-1Webinar Your Partner for OSD Success Thumbnail-1https://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/Multiparticulates_%20Transforming%20Oral%20Therapies%20Through%20Patient-Centric%20Design.pngMultiparticulates_ Transforming Oral Therapies Through Patient-Centric DesignMultiparticulates_ Transforming Oral Therapies Through Patient-Centric Designhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/On-Demand%20Webinar_%20Patient%20Adherence%20for%20Isolated%20Populations%20During%20the%20Pandemic.pngOn-Demand Webinar_ Patient Adherence for Isolated Populations During the PandemicOn-Demand Webinar_ Patient Adherence for Isolated Populations During the Pandemic2026-03-30https://info.adarepharmasolutions.com/resources/right-the-first-time-in-2026-modern-strategies-to-de-risk-complex-oral-programs-under-capital-pressurehttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Fierce%20Drug%20Development%20Delivery%20Right%20First%20Time%202026%20webinar_3-31-26.mp4/medium.jpgFierce Drug Development Delivery Right First Time 2026 webinar_3-31-26Fierce Drug Development Delivery Right First Time 2026 webinar_3-31-26https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Fierce%20Drug%20Development%20Delivery%20Right%20First%20Time%202026%20webinar_3-31-26.mp4596nonohttps://info.adarepharmasolutions.com/hubfs/Right%20the%20First%20Time%20in%202026%20Modern%20Strategies%20to%20De-Risk%20Complex%20Oral%20Programs%20Under%20Capital%20Pressure%20(1).pngRight the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)Right the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/Multiparticulates_%20Transforming%20Oral%20Therapies%20Through%20Patient-Centric%20Design.pngMultiparticulates_ Transforming Oral Therapies Through Patient-Centric DesignMultiparticulates_ Transforming Oral Therapies Through Patient-Centric Designhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/The%20Future%20of%20Pharma%20Packaging_%20Trends%2c%20Technologies%2c%20and%20Patient-Centric%20Solutions.pngThe Future of Pharma Packaging_ Trends, Technologies, and Patient-Centric SolutionsThe Future of Pharma Packaging_ Trends, Technologies, and Patient-Centric Solutionshttps://info.adarepharmasolutions.com/hubfs/Webinar%20Your%20Partner%20for%20OSD%20Success%20Thumbnail-1.jpgWebinar Your Partner for OSD Success Thumbnail-1Webinar Your Partner for OSD Success Thumbnail-12026-04-14https://info.adarepharmasolutions.com/resources/endpoints-manufacturing-day-2025-battling-wildfires-in-pharma-supply-chains-cdmo-leaders-weigh-inhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Endpoints%20Manufacturing%20Day%202025%20%E2%80%93%20CDMO%20Leaders%20Discussion.mp4/medium.jpgEndpoints Manufacturing Day 2025 – CDMO Leaders DiscussionEndpoints Manufacturing Day 2025 – CDMO Leaders Discussionhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Endpoints%20Manufacturing%20Day%202025%20%E2%80%93%20CDMO%20Leaders%20Discussion.mp41923nonoEndpointsManufacturingDayBiopharmaSupplyChainsPharmaSupplyChainResilienceManufacturingStrategyCDMOLeadershttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/Scaling%203D%20Printing%20and%20Taking%20a%20Global%20Approach%20to%20Supply%20Chain%20Security-1.pngScaling 3D Printing and Taking a Global Approach to Supply Chain Security-1Scaling 3D Printing and Taking a Global Approach to Supply Chain Security-1https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/Endpoints%20Manufacturing%20Day%202025%20%E2%80%93%20CDMO%20Leaders%20Discussion-1.pngEndpoints Manufacturing Day 2025 – CDMO Leaders Discussion-1Endpoints Manufacturing Day 2025 – CDMO Leaders Discussion-1https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/CEO%20Tom%20Sellig%20on%20Important%20Industry%20Challenges.pngCEO Tom Sellig on Important Industry ChallengesCEO Tom Sellig on Important Industry Challengeshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/Fast%2c%20Flexible%2c%20Focused_%20The%20Secrets%20of%20a%20Successful%20CDMO%20Partnership.pngFast, Flexible, Focused_ The Secrets of a Successful CDMO PartnershipFast, Flexible, Focused_ The Secrets of a Successful CDMO Partnership2026-03-30https://info.adarepharmasolutions.com/resources/reshaping-drug-development-with-3d-screen-printinghttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/Reshaping%20Drug%20Development%20With%203D%20Screen%20Printing.pngReshaping Drug Development With 3D Screen PrintingReshaping Drug Development With 3D Screen Printinghttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partnerhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/resources/advancing-medication-adherence-for-pediatrics-and-patients-with-dysphagiahttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Advancing%20Medication%20Adherence%20for%20Pediatrics%20and%20Patients%20with%20Dysphagia.mp4/medium.jpgAdvancing Medication Adherence for Pediatrics and Patients with DysphagiaAdvancing Medication Adherence for Pediatrics and Patients with Dysphagiahttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Advancing%20Medication%20Adherence%20for%20Pediatrics%20and%20Patients%20with%20Dysphagia.mp42135nonoDysphagiaSolutionsPatientCentricDosageOralDrugDeliveryMedicationAdherencePediatricFormulationhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/Multiparticulates_%20Transforming%20Oral%20Therapies%20Through%20Patient-Centric%20Design.pngMultiparticulates_ Transforming Oral Therapies Through Patient-Centric DesignMultiparticulates_ Transforming Oral Therapies Through Patient-Centric Designhttps://info.adarepharmasolutions.com/hubfs/Right%20the%20First%20Time%20in%202026%20Modern%20Strategies%20to%20De-Risk%20Complex%20Oral%20Programs%20Under%20Capital%20Pressure%20(1).pngRight the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)Right the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)https://info.adarepharmasolutions.com/hubfs/Webinar%20Your%20Partner%20for%20OSD%20Success%20Thumbnail-1.jpgWebinar Your Partner for OSD Success Thumbnail-1Webinar Your Partner for OSD Success Thumbnail-1https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/Advancing%20Medication%20Adherence%20for%20Pediatrics%20and%20Patients%20with%20Dysphagia.pngAdvancing Medication Adherence for Pediatrics and Patients with DysphagiaAdvancing Medication Adherence for Pediatrics and Patients with Dysphagiahttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/newsroom/adare-pharmaceuticals-and-nls-pharmaceutics-collaborate-to-develop-mazindol-controlled-release-cr-for-the-treatment-of-adhd-and-narcolepsyhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-05-18https://info.adarepharmasolutions.com/resources/probing-the-source-of-an-unstable-impurity-and-controlling-its-formation-at-releasehttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partnerhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/resources/type/webinars2026-04-20https://info.adarepharmasolutions.com/newsroom/adare-and-laxxon-announce-3d-printing-collaborationhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-05-18https://info.adarepharmasolutions.com/resources/harris-williams-discusses-growth-with-the-ceo-of-adare-pharma-solutionshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/CEO%20Tom%20Sellig%20on%20Important%20Industry%20Challenges.pngCEO Tom Sellig on Important Industry ChallengesCEO Tom Sellig on Important Industry Challengeshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/Endpoints%20Manufacturing%20Day%202025%20%E2%80%93%20CDMO%20Leaders%20Discussion-1.pngEndpoints Manufacturing Day 2025 – CDMO Leaders Discussion-1Endpoints Manufacturing Day 2025 – CDMO Leaders Discussion-1https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/Scaling%203D%20Printing%20and%20Taking%20a%20Global%20Approach%20to%20Supply%20Chain%20Security-1.pngScaling 3D Printing and Taking a Global Approach to Supply Chain Security-1Scaling 3D Printing and Taking a Global Approach to Supply Chain Security-1https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Blog%20Thumbnails/Harris%20Williams%20Discusses%20Growth%20With%20the%20CEO%20of%20Adare%20Pharma%20Solutions%20Thumbnail.pngHarris Williams Discusses Growth With the CEO of Adare Pharma Solutions ThumbnailHarris Williams Discusses Growth With the CEO of Adare Pharma Solutions Thumbnailhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/Harris%20Williams%20Discusses%20Growth%20With%20the%20CEO%20of%20Adare%20Pharma%20Solutions-1.pngHarris Williams Discusses Growth With the CEO of Adare Pharma Solutions-1Harris Williams Discusses Growth With the CEO of Adare Pharma Solutions-12026-03-30https://info.adarepharmasolutions.com/resources/formulation-considerations-for-pediatric-populationshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partnerhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/newsroom/adare-pharma-solutions-acquires-frontida-biopharm-to-expand-leading-cdmo-offeringshttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-05-18https://info.adarepharmasolutions.com/resources/technology-challenge-which-drug-delivery-technologies-should-you-know-about-in-2024/https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Technology%20Challenge%20Which%20Drug%20Delivery%20Technologies%20Should%20You%20Know%20About%20in%202024.mp4/medium.jpgTechnology Challenge: Which Drug Delivery Technologies Should You Know About in 2024Technology Challenge Which Drug Delivery Technologies Should You Know About in 2024https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Technology%20Challenge%20Which%20Drug%20Delivery%20Technologies%20Should%20You%20Know%20About%20in%202024.mp42996nonoInhalationTherapiesMultiParticulatesDrugDeliveryTechnologiesTasteMaskingPatientCentricDosinghttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Speaker%20Presentations/Presentation%20From%20Ambiguity%20To%20Action_%20The%20FDA%E2%80%99s%20New%20Nitrosamine%20Guidance.pngPresentation From Ambiguity To Action_ The FDA’s New Nitrosamine GuidancePresentation From Ambiguity To Action_ The FDA’s New Nitrosamine Guidance2026-03-24https://info.adarepharmasolutions.com/weglot-testhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-05-15https://info.adarepharmasolutions.com/newsroom/adare-pharmaceuticals-appoints-joseph-del-buono-as-vice-president-finance-and-chief-financial-officerhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-05-18https://info.adarepharmasolutions.com/resources/nitrosamine-mitigation-webinarhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Nitrosamine%20Impurities%20Deadline%20Are%20Your%20Products%20Compliant%3F.mp4/medium.jpgNitrosamine Impurities Deadline: Are Your Products Compliant?Nitrosamine Impurities Deadline Are Your Products Compliant?https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Nitrosamine%20Impurities%20Deadline%20Are%20Your%20Products%20Compliant%3F.mp43556nonoNitrosamineImpuritiesNDSRIsComplianceFDAGuidanceMitigationStrategiesDrugSafetyhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/Multiparticulates_%20Transforming%20Oral%20Therapies%20Through%20Patient-Centric%20Design.pngMultiparticulates_ Transforming Oral Therapies Through Patient-Centric DesignMultiparticulates_ Transforming Oral Therapies Through Patient-Centric Designhttps://info.adarepharmasolutions.com/hubfs/Right%20the%20First%20Time%20in%202026%20Modern%20Strategies%20to%20De-Risk%20Complex%20Oral%20Programs%20Under%20Capital%20Pressure%20(1).pngRight the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)Right the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)https://info.adarepharmasolutions.com/hubfs/Webinar%20Your%20Partner%20for%20OSD%20Success%20Thumbnail-1.jpgWebinar Your Partner for OSD Success Thumbnail-1Webinar Your Partner for OSD Success Thumbnail-1https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/Nitrosamine%20Impurities%20Deadline_%20Are%20Your%20Products%20Compliant-1.pngNitrosamine Impurities Deadline_ Are Your Products Compliant-1Nitrosamine Impurities Deadline_ Are Your Products Compliant-12026-03-30https://info.adarepharmasolutions.com/resources/type/esg-resources2026-04-20https://info.adarepharmasolutions.com/resources/minitablets-a-patient-centric-dosage-formhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Minitablets%20%E2%80%93%20a%20Patient%20Centric%20Dosage%20Form.mp4/medium.jpgMinitablets – a Patient Centric Dosage FormMinitablets – a Patient Centric Dosage Formhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Minitablets%20%E2%80%93%20a%20Patient%20Centric%20Dosage%20Form.mp41607nonoMiniTabletsDrugDeliverySystemsTherapyCompliancePatientCentricityPharmaceuticalFormulationhttps://info.adarepharmasolutions.com/hubfs/Right%20the%20First%20Time%20in%202026%20Modern%20Strategies%20to%20De-Risk%20Complex%20Oral%20Programs%20Under%20Capital%20Pressure%20(1).pngRight the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)Right the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)https://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/Minitablets%20%E2%80%93%20a%20Patient%20Centric%20Dosage%20Form.pngMinitablets – a Patient Centric Dosage FormMinitablets – a Patient Centric Dosage Formhttps://info.adarepharmasolutions.com/hubfs/Webinar%20Your%20Partner%20for%20OSD%20Success%20Thumbnail-1.jpgWebinar Your Partner for OSD Success Thumbnail-1Webinar Your Partner for OSD Success Thumbnail-1https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/Multiparticulates_%20Transforming%20Oral%20Therapies%20Through%20Patient-Centric%20Design.pngMultiparticulates_ Transforming Oral Therapies Through Patient-Centric DesignMultiparticulates_ Transforming Oral Therapies Through Patient-Centric Design2026-03-30https://info.adarepharmasolutions.com/newsroom/typehttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-05-19https://info.adarepharmasolutions.com/resources/patient-centric-dosage-forms-strategies-for-acceptance-and-adherence-in-pediatric-and-geriatric-populationhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partnerhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-24https://info.adarepharmasolutions.com/resources/fast-flexible-flawless-manufacturing-in-the-u.shttps://info.adarepharmasolutions.com/hubfs/Manufacturing%20and%20Regional%20Supply%20Day%20Presentation%20EU%20Adare%20-%20Armando%20Pedoto%20-%205-6-2026.mp4/medium.jpgManufacturing and Regional Supply Day Presentation EU Adare - Armando Pedoto - 5-6-2026Manufacturing and Regional Supply Day Presentation EU Adare - Armando Pedoto - 5-6-2026https://info.adarepharmasolutions.com/hubfs/Manufacturing%20and%20Regional%20Supply%20Day%20Presentation%20EU%20Adare%20-%20Armando%20Pedoto%20-%205-6-2026.mp4320nonohttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partnerhttps://info.adarepharmasolutions.com/hubfs/Manufacturing%20in%20EU.pngManufacturing in EUManufacturing in EUhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-06-25https://info.adarepharmasolutions.com/resources/cphi-milan-2024https://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/resources/advancements-in-glp-1-analog-formulation-development-overcoming-challenges-in-oral-deliveryhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partner2026-03-30https://info.adarepharmasolutions.com/resources/outsourced-pharma-capacity-update-2023-renard-jackson-presentationhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Outsourced%20Pharma%20Capacity%20Update%202023%20-%20Renard%20Jackson%20Presentation.mp4/medium.jpgOutsourced Pharma Capacity Update 2023 - Renard Jackson PresentationExplore the innovative advancements at Adare Pharma Solutions as Renard Jackson, Vice President of North American Contract Service Operations, presents a comprehensive overview of their state-of-the-art capabilities in oral dosage forms. In this video, you'll learn about: - Adare's integrated end-to-end contract development and manufacturing organization (CDMO) services, emphasizing high potency capacity. - Recent expansions in packaging and serialization capabilities at their Philadelphia facility, ensuring compliance with FDA requirements. - The cutting-edge technology platforms that support product development, including taste masking and customized release solutions. Key takeaways from this presentation include: - Insights into Adare's proven track record of over 65 products sold in more than 100 countries, demonstrating their global reach and expertise. - An overview of the newly validated high-speed blistering capabilities that enhance production efficiency while maintaining stringent quality standards. - Detailed discussions on the significant investments made to expand DEA Schedule II capacity, ensuring robust compliance and operational excellence. Join us as we delve into the future of pharmaceutical manufacturing, showcasing how Adare Pharma Solutions is poised to meet the evolving needs of the industry. Whether you're a decision-maker in biopharmaceuticals or a procurement leader seeking reliable outsourcing partnerships, this presentation provides valuable insights into accelerating drug development and optimizing operational workflows. Don’t miss out on discovering how Adare is redefining pharmaceutical services for a better tomorrow.https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Outsourced%20Pharma%20Capacity%20Update%202023%20-%20Renard%20Jackson%20Presentation.mp4793nonohttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-24https://info.adarepharmasolutions.com/newsroom/adare-acquires-egalets-proprietary-parvulet-technology-platformhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-05-18https://info.adarepharmasolutions.com/newsroom/2025/01/getting-economic-development-done-governor-shapiro-is-making-pennsylvania-more-competitive-attracting-investment-and-creating-jobshttps://info.adarepharmasolutions.com/hubfs/27098_gov_publicSafety_06-200x200.webp27098_gov_publicSafety_06-200x20027098_gov_publicSafety_06-200x200https://info.adarepharmasolutions.com/hubfs/27098_gov_publicSafety_12-200x200.webp27098_gov_publicSafety_12-200x20027098_gov_publicSafety_12-200x200https://info.adarepharmasolutions.com/hubfs/27098_gov_publicSafety_19-200x200.webp27098_gov_publicSafety_19-200x20027098_gov_publicSafety_19-200x200https://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/27098_gov_publicSafety_07-200x200.webp27098_gov_publicSafety_07-200x20027098_gov_publicSafety_07-200x200https://info.adarepharmasolutions.com/hubfs/27098_gov_publicSafety_18-200x200.webp27098_gov_publicSafety_18-200x20027098_gov_publicSafety_18-200x200https://info.adarepharmasolutions.com/hubfs/27098_gov_publicSafety_21-200x200.webp27098_gov_publicSafety_21-200x20027098_gov_publicSafety_21-200x200https://info.adarepharmasolutions.com/hubfs/27098_gov_publicSafety_22-200x200.webp27098_gov_publicSafety_22-200x20027098_gov_publicSafety_22-200x200https://info.adarepharmasolutions.com/hubfs/27098_gov_publicSafety_02-200x200.webp27098_gov_publicSafety_02-200x20027098_gov_publicSafety_02-200x2002026-05-18https://info.adarepharmasolutions.com/resources/laxxon-medical-3d-screen-printinghttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Laxxon%20Medical%203D%20Screen%20Printing.mp4/medium.jpgLaxxon Medical: 3D Screen PrintingLaxxon Medical 3D Screen Printinghttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Laxxon%20Medical%203D%20Screen%20Printing.mp4162nonoIndustrialProcessLaxxonMedical3DScreenPrintingProductionExperimentationLaboratoryMachineryhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/resources/scaling-for-growth-strategic-and-structural-challenges-for-cdmoshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partnerhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/resources/technologies-and-patient-centric-solutions-to-address-the-paradigm-treat-the-patient-not-the-diseasehttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-24https://info.adarepharmasolutions.com/resources/the-evolution-of-a-cdmohttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Blog%20Thumbnails/The%20Evolution%20of%20a%20CDMO.pngThe Evolution of a CDMOThe Evolution of a CDMOhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/Scaling%203D%20Printing%20and%20Taking%20a%20Global%20Approach%20to%20Supply%20Chain%20Security-1.pngScaling 3D Printing and Taking a Global Approach to Supply Chain Security-1Scaling 3D Printing and Taking a Global Approach to Supply Chain Security-1https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/Endpoints%20Manufacturing%20Day%202025%20%E2%80%93%20CDMO%20Leaders%20Discussion-1.pngEndpoints Manufacturing Day 2025 – CDMO Leaders Discussion-1Endpoints Manufacturing Day 2025 – CDMO Leaders Discussion-1https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/The%20Evolution%20Of%20A%20CDMO.pngThe Evolution Of A CDMOThe Evolution Of A CDMOhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/CEO%20Tom%20Sellig%20on%20Important%20Industry%20Challenges.pngCEO Tom Sellig on Important Industry ChallengesCEO Tom Sellig on Important Industry Challenges2026-03-30https://info.adarepharmasolutions.com/resources/innovations-in-dosage-form-design-pediatrics-patients-with-dysphagiahttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partnerhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Speaker%20Presentations/Innovations-in-Dosage-Form-Design-Pediatrics-Patients-with-Dysphagia.pngInnovations-in-Dosage-Form-Design-Pediatrics-Patients-with-DysphagiaInnovations-in-Dosage-Form-Design-Pediatrics-Patients-with-Dysphagiahttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-24https://info.adarepharmasolutions.com/resources/adare-headquarters-ribbon-cutting-ceremonyhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Adare%20Headquarters%20Ribbon%20Cutting%20Ceremony.mp4/medium.jpgAdare Headquarters Ribbon Cutting CeremonyAdare Headquarters Ribbon Cutting Ceremonyhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Adare%20Headquarters%20Ribbon%20Cutting%20Ceremony.mp4229nonoAdareRibbonCuttingLifeSciencesIndustryCorporateInvestmentPhiladelphiaBusinessPackagingCenterhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/newsroom/adare-pharmaceuticals-announces-changes-to-executive-leadership-teamhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-05-18https://info.adarepharmasolutions.com/resources/interview-precision-particle-fabricationhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partnerhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/resources/pediatric-drug-development-trendshttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partner2026-03-30https://info.adarepharmasolutions.com/resources/strategies-for-effective-patient-centric-dosage-formulationshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Strategies%20for%20Effective%20Patient-Centric%20Dosage%20Formulations.mp4/medium.jpgStrategies for Effective Patient-Centric Dosage FormulationsStrategies for Effective Patient-Centric Dosage Formulationshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Strategies%20for%20Effective%20Patient-Centric%20Dosage%20Formulations.mp45454nonoMedicalResearchPharmaceuticalAnalysisProductDevelopmentClinicalPracticePatientCentricFormulationshttps://info.adarepharmasolutions.com/hubfs/Right%20the%20First%20Time%20in%202026%20Modern%20Strategies%20to%20De-Risk%20Complex%20Oral%20Programs%20Under%20Capital%20Pressure%20(1).pngRight the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)Right the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/Strategies%20for%20Effective%20Patient-Centric%20Dosage%20Formulations.pngStrategies for Effective Patient-Centric Dosage FormulationsStrategies for Effective Patient-Centric Dosage Formulationshttps://info.adarepharmasolutions.com/hubfs/Webinar%20Your%20Partner%20for%20OSD%20Success%20Thumbnail-1.jpgWebinar Your Partner for OSD Success Thumbnail-1Webinar Your Partner for OSD Success Thumbnail-1https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/Multiparticulates_%20Transforming%20Oral%20Therapies%20Through%20Patient-Centric%20Design.pngMultiparticulates_ Transforming Oral Therapies Through Patient-Centric DesignMultiparticulates_ Transforming Oral Therapies Through Patient-Centric Designhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/resources/enhancing-precision-in-personalized-medicine-combining-powdose-and-diffucaps-for-precise-solid-oral-dosinghttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partnerhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/resources/typehttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-04-20https://info.adarepharmasolutions.com/newsroom/type/press-release-archives2026-05-19https://info.adarepharmasolutions.com/resources/drug-delivery-and-formulation-summit-breaking-the-barriers-of-pediatric-developmenthttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partnerhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Blog%20Thumbnails/DDF-2024-imag.webpDDF-2024-imagDDF-2024-imag2026-03-24https://info.adarepharmasolutions.com/resources/dissolution-development-of-parvulet-technology-oral-tablets-scientific-briefinghttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partner2026-03-30https://info.adarepharmasolutions.com/resources/overcoming-the-challenges-of-pediatric-formulation-ebookhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partner2026-03-30https://info.adarepharmasolutions.com/resources/2025-summit-on-innovations-multiparticulates-for-modified-release-systemshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Blog%20Thumbnails/Innovations-Summit-Presentation.webpInnovations-Summit-PresentationInnovations-Summit-Presentationhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partner2026-03-24https://info.adarepharmasolutions.com/resources/cphi-2025-preview-event-adare-ceo-tom-sellig-interviewhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/CEO%20Tom%20Sellig%20on%20Important%20Industry%20Challenges.mp4/medium.jpgCEO Tom Sellig on Important Industry ChallengesCEO Tom Sellig on Important Industry Challengeshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/CEO%20Tom%20Sellig%20on%20Important%20Industry%20Challenges.mp4337nonoPharmaceuticalPackaging3DPrintingTechnologyQualityManagementSupplyChainOptimizationAdareCDMOhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/CEO%20Tom%20Sellig%20on%20Important%20Industry%20Challenges.pngCEO Tom Sellig on Important Industry ChallengesCEO Tom Sellig on Important Industry Challengeshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/Scaling%203D%20Printing%20and%20Taking%20a%20Global%20Approach%20to%20Supply%20Chain%20Security-1.pngScaling 3D Printing and Taking a Global Approach to Supply Chain Security-1Scaling 3D Printing and Taking a Global Approach to Supply Chain Security-1https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/Fast%2c%20Flexible%2c%20Focused_%20The%20Secrets%20of%20a%20Successful%20CDMO%20Partnership.pngFast, Flexible, Focused_ The Secrets of a Successful CDMO PartnershipFast, Flexible, Focused_ The Secrets of a Successful CDMO Partnershiphttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/Endpoints%20Manufacturing%20Day%202025%20%E2%80%93%20CDMO%20Leaders%20Discussion-1.pngEndpoints Manufacturing Day 2025 – CDMO Leaders Discussion-1Endpoints Manufacturing Day 2025 – CDMO Leaders Discussion-12026-03-30https://info.adarepharmasolutions.com/resources/drug-delivery-and-formulation-the-perfect-match-between-patient-needs-and-optimized-manufacturinghttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partnerhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Speaker%20Presentations/Drug%20Delivery%20and%20Formulation%20Summit%20-%20The%20Perfect%20Match%20Between%20Patient%20Needs%20and%20Optimized%20Manufacturing.pngDrug Delivery and Formulation Summit - The Perfect Match Between Patient Needs and Optimized ManufacturingDrug Delivery and Formulation Summit - The Perfect Match Between Patient Needs and Optimized Manufacturing2026-03-24https://info.adarepharmasolutions.com/resources/life-cycle-management-strategies-for-patients-with-swallowing-disordershttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Life%20Cycle%20Management%20Strategies%20for%20Patients%20with%20Swallowing%20Disorders.mp4/medium.jpgLife Cycle Management Strategies for Patients with Swallowing DisordersLife Cycle Management Strategies for Patients with Swallowing Disordershttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Life%20Cycle%20Management%20Strategies%20for%20Patients%20with%20Swallowing%20Disorders.mp43745nonoPatientComplianceTasteMaskingLifeCycleManagementSwallowingDisordersPharmaceuticalTechnologieshttps://info.adarepharmasolutions.com/hubfs/Webinar%20Your%20Partner%20for%20OSD%20Success%20Thumbnail-1.jpgWebinar Your Partner for OSD Success Thumbnail-1Webinar Your Partner for OSD Success Thumbnail-1https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/Multiparticulates_%20Transforming%20Oral%20Therapies%20Through%20Patient-Centric%20Design.pngMultiparticulates_ Transforming Oral Therapies Through Patient-Centric DesignMultiparticulates_ Transforming Oral Therapies Through Patient-Centric Designhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Right%20the%20First%20Time%20in%202026%20Modern%20Strategies%20to%20De-Risk%20Complex%20Oral%20Programs%20Under%20Capital%20Pressure%20(1).pngRight the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)Right the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/Life%20Cycle%20Management%20Strategies%20for%20Patients%20with%20Swallowing%20Disorders%20%E2%80%93%20a%20Patient%20Centric%20Dosage%20Form.pngLife Cycle Management Strategies for Patients with Swallowing Disorders – a Patient Centric Dosage FormLife Cycle Management Strategies for Patients with Swallowing Disorders – a Patient Centric Dosage Form2026-03-30https://info.adarepharmasolutions.com/resources/customized-release-through-dispersed-dosage-formats-driving-patient-acceptance-and-therapeutic-performancehttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partnerhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/resources/supplier-code-of-conducthttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Supplier%20Code%20of%20Conduct.pngSupplier Code of ConductSupplier Code of Conducthttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partner2026-03-23https://info.adarepharmasolutions.com/resources/nitrosaminehttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/Nitrosamine%20Impurities%20Deadline_%20Are%20Your%20Products%20Compliant.pngNitrosamine Impurities Deadline_ Are Your Products CompliantNitrosamine Impurities Deadline_ Are Your Products Complianthttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partnerhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/resources/selecting-a-cdmo-a-guide-to-successful-collaborationhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Selecting%20a%20CDMO%20A%20Guide%20to%20Successful%20Collaboration.mp4/medium.jpgSelecting a CDMO: A Guide to Successful CollaborationSelecting a CDMO A Guide to Successful Collaborationhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Selecting%20a%20CDMO%20A%20Guide%20to%20Successful%20Collaboration.mp43712nonoCDMOSelectionContractManufacturingDrugDevelopmentSuccessfulCollaborationPharmaOutsourcinghttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/Multiparticulates_%20Transforming%20Oral%20Therapies%20Through%20Patient-Centric%20Design.pngMultiparticulates_ Transforming Oral Therapies Through Patient-Centric DesignMultiparticulates_ Transforming Oral Therapies Through Patient-Centric Designhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/Selecting%20a%20CDMO_%20A%20Guide%20to%20Successful%20Collaboration.pngSelecting a CDMO_ A Guide to Successful CollaborationSelecting a CDMO_ A Guide to Successful Collaborationhttps://info.adarepharmasolutions.com/hubfs/Webinar%20Your%20Partner%20for%20OSD%20Success%20Thumbnail-1.jpgWebinar Your Partner for OSD Success Thumbnail-1Webinar Your Partner for OSD Success Thumbnail-1https://info.adarepharmasolutions.com/hubfs/Right%20the%20First%20Time%20in%202026%20Modern%20Strategies%20to%20De-Risk%20Complex%20Oral%20Programs%20Under%20Capital%20Pressure%20(1).pngRight the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)Right the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)2026-03-30https://info.adarepharmasolutions.com/newsroom/2026/01/adare-pharma-solutions-transforms-mro-procurement-with-rs-italia-up-to-30-savings-and-supplier-rationalizationhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-05-18https://info.adarepharmasolutions.com/resources/the-future-of-pharma-packaging-trends-technologies-and-patient-centric-solutionshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/The%20Future%20of%20Pharma%20Packaging%20Trends%2c%20Technologies%2c%20and%20Patient-Centric%20Solutions.mp4/medium.jpgThe Future of Pharma Packaging: Trends, Technologies, and Patient-Centric SolutionsThe Future of Pharma Packaging Trends, Technologies, and Patient-Centric Solutionshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/The%20Future%20of%20Pharma%20Packaging%20Trends%2c%20Technologies%2c%20and%20Patient-Centric%20Solutions.mp43760nonohttps://info.adarepharmasolutions.com/hubfs/Right%20the%20First%20Time%20in%202026%20Modern%20Strategies%20to%20De-Risk%20Complex%20Oral%20Programs%20Under%20Capital%20Pressure%20(1).pngRight the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)Right the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/The%20Future%20of%20Pharma%20Packaging_%20Trends%2c%20Technologies%2c%20and%20Patient-Centric%20Solutions.pngThe Future of Pharma Packaging_ Trends, Technologies, and Patient-Centric SolutionsThe Future of Pharma Packaging_ Trends, Technologies, and Patient-Centric Solutionshttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/Multiparticulates_%20Transforming%20Oral%20Therapies%20Through%20Patient-Centric%20Design.pngMultiparticulates_ Transforming Oral Therapies Through Patient-Centric DesignMultiparticulates_ Transforming Oral Therapies Through Patient-Centric Designhttps://info.adarepharmasolutions.com/hubfs/Webinar%20Your%20Partner%20for%20OSD%20Success%20Thumbnail-1.jpgWebinar Your Partner for OSD Success Thumbnail-1Webinar Your Partner for OSD Success Thumbnail-12026-03-30https://info.adarepharmasolutions.com/resources/fast-flexible-focused-the-secrets-of-a-successful-cdmo-partnershiphttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/Fast%2c%20Flexible%2c%20Focused_%20The%20Secrets%20of%20a%20Successful%20CDMO%20Partnership.pngFast, Flexible, Focused_ The Secrets of a Successful CDMO PartnershipFast, Flexible, Focused_ The Secrets of a Successful CDMO Partnershiphttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/CEO%20Tom%20Sellig%20on%20Important%20Industry%20Challenges.pngCEO Tom Sellig on Important Industry ChallengesCEO Tom Sellig on Important Industry Challengeshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/Scaling%203D%20Printing%20and%20Taking%20a%20Global%20Approach%20to%20Supply%20Chain%20Security-1.pngScaling 3D Printing and Taking a Global Approach to Supply Chain Security-1Scaling 3D Printing and Taking a Global Approach to Supply Chain Security-1https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Blog%20Thumbnails/Fast%2c%20Flexible%2c%20Focused%20The%20Secrets%20of%20a%20Successful%20CDMO%20Partnership%20Thumbnail.pngFast, Flexible, Focused The Secrets of a Successful CDMO Partnership ThumbnailFast, Flexible, Focused The Secrets of a Successful CDMO Partnership Thumbnailhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/Endpoints%20Manufacturing%20Day%202025%20%E2%80%93%20CDMO%20Leaders%20Discussion-1.pngEndpoints Manufacturing Day 2025 – CDMO Leaders Discussion-1Endpoints Manufacturing Day 2025 – CDMO Leaders Discussion-12026-03-30https://info.adarepharmasolutions.com/resources/streamline-early-stage-development-to-reach-the-clinic-fasterhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partner2026-03-30https://info.adarepharmasolutions.com/resources/case-study-zenpep-mmts-minitabs-delivers-child-friendly-dosing-for-toddlershttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Enhancing%20Serialization%20&%20Automation%20to%20Support%20Customer%20Success.pngEnhancing Serialization & Automation to Support Customer SuccessEnhancing Serialization & Automation to Support Customer Successhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Delivering%20a%20Critical%20Therapy%20From%20FDA%20Approval%20to%20Patients%20in%2010%20Days.pngDelivering a Critical Therapy From FDA Approval to Patients in 10 DaysDelivering a Critical Therapy From FDA Approval to Patients in 10 Dayshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Unlocking%20Higher%20Complex%20Capsule%20Yields%20Through%20More%20Efficient%20Manufacturing.pngUnlocking Higher Complex Capsule Yields Through More Efficient ManufacturingUnlocking Higher Complex Capsule Yields Through More Efficient Manufacturinghttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Zenpep-MMTSTM%20Minitabs%20Delivers%20Child-Friendly%20Dosing%20for%20Toddlers.pngZenpep-MMTSTM Minitabs Delivers Child-Friendly Dosing for ToddlersZenpep-MMTSTM Minitabs Delivers Child-Friendly Dosing for Toddlers2026-05-21https://info.adarepharmasolutions.com/resources/controlled-release-society-a-patient-centric-approach-for-chronotherapyhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partnerhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Blog%20Thumbnails/CRS-2024.webpCRS-2024CRS-20242026-03-24https://info.adarepharmasolutions.com/resources/microcaps-outperforms-standard-bead-intermediate-formulationshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Delivering%20a%20Critical%20Therapy%20From%20FDA%20Approval%20to%20Patients%20in%2010%20Days.pngDelivering a Critical Therapy From FDA Approval to Patients in 10 DaysDelivering a Critical Therapy From FDA Approval to Patients in 10 Dayshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Unlocking%20Higher%20Complex%20Capsule%20Yields%20Through%20More%20Efficient%20Manufacturing.pngUnlocking Higher Complex Capsule Yields Through More Efficient ManufacturingUnlocking Higher Complex Capsule Yields Through More Efficient Manufacturinghttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Enhancing%20Serialization%20&%20Automation%20to%20Support%20Customer%20Success.pngEnhancing Serialization & Automation to Support Customer SuccessEnhancing Serialization & Automation to Support Customer Success2026-03-30https://info.adarepharmasolutions.com/resources/2023-american-association-of-pharmaceutical-scientists-aaps-precision-microspheres-then-nowhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partnerhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-24https://info.adarepharmasolutions.com/resources/ceo-tom-sellig-interview-with-life-science-marketing-radiohttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/CEO%20Tom%20Sellig%20Interview%20With%20Life%20Science%20Marketing%20Radio.mp4/medium.jpgCEO Tom Sellig Interview With Life Science Marketing RadioCEO Tom Sellig Interview With Life Science Marketing Radiohttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/CEO%20Tom%20Sellig%20Interview%20With%20Life%20Science%20Marketing%20Radio.mp41140nonoClientCentricSolutionsSmallMoleculeTechnologiesPostbioticInnovationOralSolidDevelopmentPharmaMarketingStrategieshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/Scaling%203D%20Printing%20and%20Taking%20a%20Global%20Approach%20to%20Supply%20Chain%20Security-1.pngScaling 3D Printing and Taking a Global Approach to Supply Chain Security-1Scaling 3D Printing and Taking a Global Approach to Supply Chain Security-1https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/CEO%20Tom%20Sellig%20on%20Important%20Industry%20Challenges.pngCEO Tom Sellig on Important Industry ChallengesCEO Tom Sellig on Important Industry Challengeshttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/Endpoints%20Manufacturing%20Day%202025%20%E2%80%93%20CDMO%20Leaders%20Discussion-1.pngEndpoints Manufacturing Day 2025 – CDMO Leaders Discussion-1Endpoints Manufacturing Day 2025 – CDMO Leaders Discussion-1https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/CEO%20Tom%20Sellig%20Interview%20With%20Life%20Science%20Marketing%20Radio-1.pngCEO Tom Sellig Interview With Life Science Marketing Radio-1CEO Tom Sellig Interview With Life Science Marketing Radio-12026-03-30https://info.adarepharmasolutions.com/newsroom/thomas-h.-lee-partners-and-frazier-healthcare-partners-acquire-adarehttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-05-18https://info.adarepharmasolutions.com/newsroom/the-challenges-of-formulating-medicines-for-childrenhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-05-18https://info.adarepharmasolutions.com/resources/three-dimensional-screen-printing-technology-enables-sequential-release-of-carbidopa-and-levodopahttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partnerhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/Three-Dimensional%20Screen%20Printing%20Technology%20Enables%20Sequential%20Release%20of%20Carbidopa%20and%20Levodopa%20%E2%80%93%20A%20New%20Approach%20Improving%20Levodopa%20Delivery%20for%20Treating%20Parkinson%E2%80%99s%20Disease.pngThree-Dimensional Screen Printing Technology Enables Sequential Release of Carbidopa and Levodopa – A New Approach Improving Levodopa Delivery for Treating Parkinson’s DiseaseThree-Dimensional Screen Printing Technology Enables Sequential Release of Carbidopa and Levodopa – A New Approach Improving Levodopa Delivery for Treating Parkinson’s Disease2026-03-30https://info.adarepharmasolutions.com/newsroom/global-cdmo-adare-pharma-solutions-harmonizing-quality-with-veeva-vault-quality-suitehttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-05-18https://info.adarepharmasolutions.com/resources/adare-profile-video-from-pharmaceutical-outsourcinghttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Pharmaceutical%20Outsourcing%20Adare%20Profile%20Video.mp4/medium.jpgPharmaceutical Outsourcing: Adare Profile VideoPharmaceutical Outsourcing Adare Profile Videohttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Pharmaceutical%20Outsourcing%20Adare%20Profile%20Video.mp4233nonoFormulationSolutionsCDMOServicesSupplyChainManagementOralSolidDosePharmaceuticalOutsourcinghttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/resources/parvulethttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Parvulet%C2%AE%20Technology.mp4/medium.jpgParvulet® TechnologyParvulet® Technologyhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Parvulet%C2%AE%20Technology.mp458nonoChildSafetyMedicationAntiDrugResistanceHighDrugLoadingParvuletTechnologyPatientCentricDosinghttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/resources/microspheres-help-fill-an-unmet-need-in-long-acting-contraceptiveshttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partner2026-03-30https://info.adarepharmasolutions.com/resources/finding-impurities-and-controlling-formations-at-releasehttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Delivering%20a%20Critical%20Therapy%20From%20FDA%20Approval%20to%20Patients%20in%2010%20Days.pngDelivering a Critical Therapy From FDA Approval to Patients in 10 DaysDelivering a Critical Therapy From FDA Approval to Patients in 10 Dayshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Unlocking%20Higher%20Complex%20Capsule%20Yields%20Through%20More%20Efficient%20Manufacturing.pngUnlocking Higher Complex Capsule Yields Through More Efficient ManufacturingUnlocking Higher Complex Capsule Yields Through More Efficient Manufacturinghttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Finding%20Impurities%20and%20Controlling%20Formations%20at%20Release.pngFinding Impurities and Controlling Formations at ReleaseFinding Impurities and Controlling Formations at Releasehttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Enhancing%20Serialization%20&%20Automation%20to%20Support%20Customer%20Success.pngEnhancing Serialization & Automation to Support Customer SuccessEnhancing Serialization & Automation to Support Customer Successhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Thumbnail%20-%20Finding%20Impurities%20and%20Controlling%20Formations%20at%20Release.pngThumbnail - Finding Impurities and Controlling Formations at ReleaseThumbnail - Finding Impurities and Controlling Formations at Release2026-03-30https://info.adarepharmasolutions.com/resources/case-study-dry-syrup-formulation-masks-bitter-taste-in-easy-to-swallow-suspensionhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Unlocking%20Higher%20Complex%20Capsule%20Yields%20Through%20More%20Efficient%20Manufacturing.pngUnlocking Higher Complex Capsule Yields Through More Efficient ManufacturingUnlocking Higher Complex Capsule Yields Through More Efficient Manufacturinghttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Delivering%20a%20Critical%20Therapy%20From%20FDA%20Approval%20to%20Patients%20in%2010%20Days.pngDelivering a Critical Therapy From FDA Approval to Patients in 10 DaysDelivering a Critical Therapy From FDA Approval to Patients in 10 Dayshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Dry%20Syrup%20Formulation%20Masks%20Bitter%20Taste%20in%20Easy-to-Swallow%20Suspension.pngDry Syrup Formulation Masks Bitter Taste in Easy-to-Swallow SuspensionDry Syrup Formulation Masks Bitter Taste in Easy-to-Swallow Suspensionhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Enhancing%20Serialization%20&%20Automation%20to%20Support%20Customer%20Success.pngEnhancing Serialization & Automation to Support Customer SuccessEnhancing Serialization & Automation to Support Customer Successhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/newsroom/tpg-completes-acquisition-of-aptalis-pharmaceutical-technologies-summary-company-renamed-adare-pharmaceuticalshttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-05-18https://info.adarepharmasolutions.com/resources/saving-patients-lives-sharons-storyhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Saving%20Patients%E2%80%99%20Lives%20Sharon%E2%80%99s%20Story.mp4/medium.jpgSaving Patients’ Lives: Sharon’s StorySaving Patients’ Lives Sharon’s Storyhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Saving%20Patients%E2%80%99%20Lives%20Sharon%E2%80%99s%20Story.mp4132nonoPharmaceuticalImpactMedicalInnovationFamilyHealthSavingLivesHealthcareStoryhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/resources/injectable-drug-delivery-markethttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Injectable%20Drug%20Delivery%20Market.mp4/medium.jpgInjectable Drug Delivery MarketInjectable Drug Delivery Markethttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Injectable%20Drug%20Delivery%20Market.mp45792nonoInnovativeInjectablesPLGAMicrospheresStratumTechnologyDrugPackagingTrendsInjectableDrugDeliveryhttps://info.adarepharmasolutions.com/hubfs/Webinar%20Your%20Partner%20for%20OSD%20Success%20Thumbnail-1.jpgWebinar Your Partner for OSD Success Thumbnail-1Webinar Your Partner for OSD Success Thumbnail-1https://info.adarepharmasolutions.com/hubfs/Right%20the%20First%20Time%20in%202026%20Modern%20Strategies%20to%20De-Risk%20Complex%20Oral%20Programs%20Under%20Capital%20Pressure%20(1).pngRight the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)Right the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)https://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/Injectable%20Drug%20Delivery%20Market.pngInjectable Drug Delivery MarketInjectable Drug Delivery Markethttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/Multiparticulates_%20Transforming%20Oral%20Therapies%20Through%20Patient-Centric%20Design.pngMultiparticulates_ Transforming Oral Therapies Through Patient-Centric DesignMultiparticulates_ Transforming Oral Therapies Through Patient-Centric Design2026-03-30https://info.adarepharmasolutions.com/resources/from-early-development-to-commercial-launch-an-end-to-end-partnership-for-a-critical-therapyhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partner2026-03-30https://info.adarepharmasolutions.com/resources/manufacturing-for-oral-solid-dose-successhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partner2026-03-30https://info.adarepharmasolutions.com/resources/solubility-enhancement-of-itraconazole-by-amorphous-solid-dispersion-approach-using-spray-dryinghttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Blog%20Thumbnails/Solubility%20Enhancement%20Of%20Itraconazole%20By%20Amorphous%20Solid%20Dispersion%20Approach%20Using%20Spray%20Drying-1.pngSolubility Enhancement Of Itraconazole By Amorphous Solid Dispersion Approach Using Spray Drying-1Solubility Enhancement Of Itraconazole By Amorphous Solid Dispersion Approach Using Spray Drying-1https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partner2026-03-30https://info.adarepharmasolutions.com/resources/taste-masking-101-optimize-taste-and-improve-patient-outcomeshttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partner2026-03-30https://info.adarepharmasolutions.com/resources/how-oral-glp-1-therapies-are-revolutionizing-obesity-treatmenthttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partnerhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/resources/evolving-to-meet-the-future-needs-of-customers-interview-with-adare-ceo-tom-sellighttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Evolving%20to%20Meet%20the%20Future%20Needs%20of%20Customers%20Interview%20with%20Adare%20CEO%20Tom%20Sellig.mp4/medium.jpgEvolving to Meet the Future Needs of Customers: Interview with Adare CEO Tom SelligEvolving to Meet the Future Needs of Customers Interview with Adare CEO Tom Sellighttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Evolving%20to%20Meet%20the%20Future%20Needs%20of%20Customers%20Interview%20with%20Adare%20CEO%20Tom%20Sellig.mp4297nonohttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/Endpoints%20Manufacturing%20Day%202025%20%E2%80%93%20CDMO%20Leaders%20Discussion-1.pngEndpoints Manufacturing Day 2025 – CDMO Leaders Discussion-1Endpoints Manufacturing Day 2025 – CDMO Leaders Discussion-1https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/CEO%20Tom%20Sellig%20on%20Important%20Industry%20Challenges.pngCEO Tom Sellig on Important Industry ChallengesCEO Tom Sellig on Important Industry Challengeshttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/Scaling%203D%20Printing%20and%20Taking%20a%20Global%20Approach%20to%20Supply%20Chain%20Security-1.pngScaling 3D Printing and Taking a Global Approach to Supply Chain Security-1Scaling 3D Printing and Taking a Global Approach to Supply Chain Security-1https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/Evolving%20to%20Meet%20the%20Future%20Needs%20of%20Customers_%20Interview%20with%20Adare%20CEO%20Tom%20Sellig.pngEvolving to Meet the Future Needs of Customers_ Interview with Adare CEO Tom SelligEvolving to Meet the Future Needs of Customers_ Interview with Adare CEO Tom Sellig2026-03-30https://info.adarepharmasolutions.com/newsroom/adare-pharma-solutions-selects-vantage-to-lead-major-packaging-facility-upgradehttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-05-18https://info.adarepharmasolutions.com/resources/microcaps-exceeds-stringent-requirements-beyond-taste-maskinghttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Unlocking%20Higher%20Complex%20Capsule%20Yields%20Through%20More%20Efficient%20Manufacturing.pngUnlocking Higher Complex Capsule Yields Through More Efficient ManufacturingUnlocking Higher Complex Capsule Yields Through More Efficient Manufacturinghttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Enhancing%20Serialization%20&%20Automation%20to%20Support%20Customer%20Success.pngEnhancing Serialization & Automation to Support Customer SuccessEnhancing Serialization & Automation to Support Customer Successhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Delivering%20a%20Critical%20Therapy%20From%20FDA%20Approval%20to%20Patients%20in%2010%20Days.pngDelivering a Critical Therapy From FDA Approval to Patients in 10 DaysDelivering a Critical Therapy From FDA Approval to Patients in 10 Dayshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Microcaps%C2%AE%20Exceeds%20Stringent%20Requirements%20Beyond%20Taste%20Masking.pngMicrocaps® Exceeds Stringent Requirements Beyond Taste MaskingMicrocaps® Exceeds Stringent Requirements Beyond Taste Masking2026-03-30https://info.adarepharmasolutions.com/newsroom/adare-pharma-solutions-expands-executive-leadership-teamhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-05-18https://info.adarepharmasolutions.com/resources/3d-screen-printing-from-adare-pharma-solutionshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/3D%20Screen%20Printing%20from%20Adare%20Pharma%20Solutions.mp4/medium.jpg3D Screen Printing from Adare Pharma Solutions3D Screen Printing from Adare Pharma Solutionshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/3D%20Screen%20Printing%20from%20Adare%20Pharma%20Solutions.mp4171nonoMedicalDeviceInnovationAdvancedHealthcareSolutionsContinuousManufacturing3DScreenPrintingPharmaceuticalTechnologyhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/resources/early-stage-pharmaceutical-product-development-to-reach-the-clinic-fasterhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Early%20Stage%20Pharmaceutical%20Product%20Development%20to%20Reach%20the%20Clinic%20Faster.mp4/medium.jpgEarly Stage Pharmaceutical Product Development to Reach the Clinic FasterEarly Stage Pharmaceutical Product Development to Reach the Clinic Fasterhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Early%20Stage%20Pharmaceutical%20Product%20Development%20to%20Reach%20the%20Clinic%20Faster.mp43585nonoRegulatoryComplianceQuickToClinicProofOfConceptDrugDevelopmentProcessEarlyStagePharmaceuticalDevelopmenthttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/Multiparticulates_%20Transforming%20Oral%20Therapies%20Through%20Patient-Centric%20Design.pngMultiparticulates_ Transforming Oral Therapies Through Patient-Centric DesignMultiparticulates_ Transforming Oral Therapies Through Patient-Centric Designhttps://info.adarepharmasolutions.com/hubfs/Right%20the%20First%20Time%20in%202026%20Modern%20Strategies%20to%20De-Risk%20Complex%20Oral%20Programs%20Under%20Capital%20Pressure%20(1).pngRight the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)Right the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)https://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Webinar%20Your%20Partner%20for%20OSD%20Success%20Thumbnail-1.jpgWebinar Your Partner for OSD Success Thumbnail-1Webinar Your Partner for OSD Success Thumbnail-1https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/Early%20Stage%20Pharmaceutical%20Product%20Development%20to%20Reach%20the%20Clinic%20Faster.pngEarly Stage Pharmaceutical Product Development to Reach the Clinic FasterEarly Stage Pharmaceutical Product Development to Reach the Clinic Faster2026-03-30https://info.adarepharmasolutions.com/newsroom/adare-pharmaceuticals-company-spotlight-presentation-at-bio-international-2016-conventionhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-05-18https://info.adarepharmasolutions.com/newsroom/2026/04/achieve-life-sciences-announces-operational-progress-including-completion-of-technology-transfer-to-adare-pharma-solutionshttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Picture1.webpPicture1Picture12026-05-18https://info.adarepharmasolutions.com/resources/taste-masking-101-challenges-with-pediatric-flavors-for-taste-enhancement-modulationhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Taste%20Masking%20101%20(Session%203%20of%204)%20Challenges%20with%20Pediatric%20Flavors%20for%20Taste%20Enhancement%20&%20Modulation.mp4/medium.jpgTaste Masking 101 (Session 3 of 4): Challenges with Pediatric Flavors for Taste Enhancement & ModulationTaste Masking 101 (Session 3 of 4) Challenges with Pediatric Flavors for Taste Enhancement & Modulationhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Taste%20Masking%20101%20(Session%203%20of%204)%20Challenges%20with%20Pediatric%20Flavors%20for%20Taste%20Enhancement%20&%20Modulation.mp43471nonoChildrensMedicinesPatientCompliancePediatricFlavorsTasteMaskingTasteEnhancementhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/Taste%20Masking%20101%20(Session%203%20of%204)_%20Challenges%20with%20Pediatric%20Flavors%20for%20Taste%20Enhancement%20&%20Modulation.pngTaste Masking 101 (Session 3 of 4)_ Challenges with Pediatric Flavors for Taste Enhancement & ModulationTaste Masking 101 (Session 3 of 4)_ Challenges with Pediatric Flavors for Taste Enhancement & Modulationhttps://info.adarepharmasolutions.com/hubfs/Right%20the%20First%20Time%20in%202026%20Modern%20Strategies%20to%20De-Risk%20Complex%20Oral%20Programs%20Under%20Capital%20Pressure%20(1).pngRight the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)Right the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)https://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/Multiparticulates_%20Transforming%20Oral%20Therapies%20Through%20Patient-Centric%20Design.pngMultiparticulates_ Transforming Oral Therapies Through Patient-Centric DesignMultiparticulates_ Transforming Oral Therapies Through Patient-Centric Designhttps://info.adarepharmasolutions.com/hubfs/Webinar%20Your%20Partner%20for%20OSD%20Success%20Thumbnail-1.jpgWebinar Your Partner for OSD Success Thumbnail-1Webinar Your Partner for OSD Success Thumbnail-12026-03-30https://info.adarepharmasolutions.com/resources/from-service-provider-to-strategic-partnerhttps://info.adarepharmasolutions.com/hubfs/Strategic%20Partner%20Image-1.jpgStrategic Partner Image-1Strategic Partner Image-1https://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partner2026-04-29https://info.adarepharmasolutions.com/resources/meeting-the-challenges-of-pediatric-adherence-with-patient-centric-formulationshttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partner2026-03-30https://info.adarepharmasolutions.com/newsroom/2024/10/the-chamber-of-commerce-for-greater-philadelphia-announces-new-board-of-directors-and-executive-committee-members-including-adare-ceo-tom-sellighttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-05-18https://info.adarepharmasolutions.com/resources/minitablets-small-units-driving-big-advances-in-patient-centric-solutions-aaps-pharmsci-2025https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Blog%20Thumbnails/Screenshot-2026-01-20-at-2.27.01-PM.webpScreenshot-2026-01-20-at-2.27.01-PMScreenshot-2026-01-20-at-2.27.01-PMhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partnerhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-24https://info.adarepharmasolutions.com/newsroom/adare-pharma-solutions-announces-appointment-of-tom-sellig-as-chief-executive-officerhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-05-18https://info.adarepharmasolutions.com/newsroom/lannett-and-adare-enter-into-distribution-agreementhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-05-18https://info.adarepharmasolutions.com/resources/case-study-stable-microcaps-formulation-masks-bitter-hiv-drug-for-young-childrenhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Stable%20Microcaps%C2%AE%20Formulation%20Masks%20Bitter%20HIV%20Drug%20for%20Young%20Children.pngStable Microcaps® Formulation Masks Bitter HIV Drug for Young ChildrenStable Microcaps® Formulation Masks Bitter HIV Drug for Young Childrenhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Unlocking%20Higher%20Complex%20Capsule%20Yields%20Through%20More%20Efficient%20Manufacturing.pngUnlocking Higher Complex Capsule Yields Through More Efficient ManufacturingUnlocking Higher Complex Capsule Yields Through More Efficient Manufacturinghttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Delivering%20a%20Critical%20Therapy%20From%20FDA%20Approval%20to%20Patients%20in%2010%20Days.pngDelivering a Critical Therapy From FDA Approval to Patients in 10 DaysDelivering a Critical Therapy From FDA Approval to Patients in 10 Dayshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Enhancing%20Serialization%20&%20Automation%20to%20Support%20Customer%20Success.pngEnhancing Serialization & Automation to Support Customer SuccessEnhancing Serialization & Automation to Support Customer Successhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/resources/adare-technologieshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/ADARE%20Technologies.mp4/medium.jpgADARE TechnologiesADARE Technologieshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/ADARE%20Technologies.mp4392nonoOralAdministrationPharmaSolutionsDrugDeliveryADARETechnologiesInnovativeProductshttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/resources/cphi-korea-the-art-of-improving-medication-acceptance-in-pediatrics-making-medicines-taste-betterhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partner2026-03-24https://info.adarepharmasolutions.com/resources/the-journey-to-become-a-full-service-provider-an-interview-with-adare-ceo-tom-sellighttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/CEO%20Tom%20Sellig%20on%20Important%20Industry%20Challenges.pngCEO Tom Sellig on Important Industry ChallengesCEO Tom Sellig on Important Industry Challengeshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/The%20Journey%20To%20Become%20A%20Full-Service%20Provider_%20Interview%20With%20Adare%20CEO%20Tom%20Sellig.pngThe Journey To Become A Full-Service Provider_ Interview With Adare CEO Tom SelligThe Journey To Become A Full-Service Provider_ Interview With Adare CEO Tom Sellighttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/Scaling%203D%20Printing%20and%20Taking%20a%20Global%20Approach%20to%20Supply%20Chain%20Security-1.pngScaling 3D Printing and Taking a Global Approach to Supply Chain Security-1Scaling 3D Printing and Taking a Global Approach to Supply Chain Security-1https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Blog%20Thumbnails/The%20Journey%20To%20Become%20A%20Full-Service%20Provider%20Interview%20With%20Adare%20CEO%20Tom%20Sellig.pngThe Journey To Become A Full-Service Provider Interview With Adare CEO Tom SelligThe Journey To Become A Full-Service Provider Interview With Adare CEO Tom Sellighttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/Endpoints%20Manufacturing%20Day%202025%20%E2%80%93%20CDMO%20Leaders%20Discussion-1.pngEndpoints Manufacturing Day 2025 – CDMO Leaders Discussion-1Endpoints Manufacturing Day 2025 – CDMO Leaders Discussion-12026-03-30https://info.adarepharmasolutions.com/resources/adare-ceo-tom-sellig-interview-fierce-jpm-weekhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Adare%20CEO%20Tom%20Sellig%20Interview%20%E2%80%93%20Fierce%20JPM%20Week.mp4/medium.jpgAdare CEO Tom Sellig Interview – Fierce JPM WeekAdare CEO Tom Sellig Interview – Fierce JPM Weekhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Adare%20CEO%20Tom%20Sellig%20Interview%20%E2%80%93%20Fierce%20JPM%20Week.mp4801nono3DPrintingTechnologySmallMoleculeCDMOPharmaceuticalInnovationAdareCEOInterviewOralSolidDosehttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/resources/symposium-of-drug-delivery-systems-use-of-multiparticulates-and-associated-technologies-for-drug-formulation-and-developmenthttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partner2026-03-24https://info.adarepharmasolutions.com/resources/coacervation-white-paperhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partnerhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/resources/a-new-end-to-end-cdmo-takes-shape-what-does-adares-acquisition-of-frontida-mean-for-the-industryhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/CEO%20Tom%20Sellig%20on%20Important%20Industry%20Challenges.pngCEO Tom Sellig on Important Industry ChallengesCEO Tom Sellig on Important Industry Challengeshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Blog%20Thumbnails/A%20New%20End-To-End%20CDMO%20Takes%20Shape%20What%20Does%20Adare%E2%80%99s%20Acquisition%20of%20Frontida%20Mean%20for%20the%20Industry%3F.pngA New End-To-End CDMO Takes Shape What Does Adare’s Acquisition of Frontida Mean for the Industry?A New End-To-End CDMO Takes Shape What Does Adare’s Acquisition of Frontida Mean for the Industry?https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/Endpoints%20Manufacturing%20Day%202025%20%E2%80%93%20CDMO%20Leaders%20Discussion-1.pngEndpoints Manufacturing Day 2025 – CDMO Leaders Discussion-1Endpoints Manufacturing Day 2025 – CDMO Leaders Discussion-1https://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/A%20New%20End-To-End%20CDMO%20Takes%20Shape_%20What%20Does%20Adare%E2%80%99s%20Acquisition%20of%20Frontida%20Mean%20for%20the%20Industry.pngA New End-To-End CDMO Takes Shape_ What Does Adare’s Acquisition of Frontida Mean for the IndustryA New End-To-End CDMO Takes Shape_ What Does Adare’s Acquisition of Frontida Mean for the Industryhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/Scaling%203D%20Printing%20and%20Taking%20a%20Global%20Approach%20to%20Supply%20Chain%20Security-1.pngScaling 3D Printing and Taking a Global Approach to Supply Chain Security-1Scaling 3D Printing and Taking a Global Approach to Supply Chain Security-12026-03-30https://info.adarepharmasolutions.com/resources/on-time-on-target-packaging-for-a-fast-moving-product-launchhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Enhancing%20Serialization%20&%20Automation%20to%20Support%20Customer%20Success.pngEnhancing Serialization & Automation to Support Customer SuccessEnhancing Serialization & Automation to Support Customer Successhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Unlocking%20Higher%20Complex%20Capsule%20Yields%20Through%20More%20Efficient%20Manufacturing.pngUnlocking Higher Complex Capsule Yields Through More Efficient ManufacturingUnlocking Higher Complex Capsule Yields Through More Efficient Manufacturinghttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Delivering%20a%20Critical%20Therapy%20From%20FDA%20Approval%20to%20Patients%20in%2010%20Days.pngDelivering a Critical Therapy From FDA Approval to Patients in 10 DaysDelivering a Critical Therapy From FDA Approval to Patients in 10 Days2026-03-30https://info.adarepharmasolutions.com/resources/orally-disintegrating-dosage-forms-with-taste-masked-multiparticulateshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partnerhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-24https://info.adarepharmasolutions.com/resources/lifesciencespahttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Blog%20Thumbnails/Screenshot-2023-12-13-at-11.23.29-AM.webpScreenshot-2023-12-13-at-11.23.29-AMScreenshot-2023-12-13-at-11.23.29-AMhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/Endpoints%20Manufacturing%20Day%202025%20%E2%80%93%20CDMO%20Leaders%20Discussion-1.pngEndpoints Manufacturing Day 2025 – CDMO Leaders Discussion-1Endpoints Manufacturing Day 2025 – CDMO Leaders Discussion-1https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/CEO%20Tom%20Sellig%20on%20Important%20Industry%20Challenges.pngCEO Tom Sellig on Important Industry ChallengesCEO Tom Sellig on Important Industry Challengeshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/Being%20A%20Life%20Sciences%20Leader%20Interview%20with%20Tom%20Sellig-1.pngBeing A Life Sciences Leader Interview with Tom Sellig-1Being A Life Sciences Leader Interview with Tom Sellig-1https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/Scaling%203D%20Printing%20and%20Taking%20a%20Global%20Approach%20to%20Supply%20Chain%20Security-1.pngScaling 3D Printing and Taking a Global Approach to Supply Chain Security-1Scaling 3D Printing and Taking a Global Approach to Supply Chain Security-1https://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/resources/type/leadership-interviews2026-04-20https://info.adarepharmasolutions.com/resources/minitabshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Minitabs%E2%84%A2%20Technology.mp4/medium.jpgMinitabs™ TechnologyMinitabs™ Technologyhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Minitabs%E2%84%A2%20Technology.mp457nonoMinitabsTechnologyMultiMiniTabletSystemComponentsProductAdvertisementDosingOptionshttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/newsroom/adare-pharmaceuticals-partners-with-cincinnati-childrens-on-innovation-fundhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-05-18https://info.adarepharmasolutions.com/newsroom/adare-pharma-solutions-to-expand-packaging-warehousing-capabilities-in-europehttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-05-18https://info.adarepharmasolutions.com/resources/how-to-achieve-precise-and-flexible-dosing-with-multiparticulateshttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partner2026-03-30https://info.adarepharmasolutions.com/resources/formulation-of-monodisperse-controlled-release-quetiapine-microspheres-nonoyama-scientific-briefinghttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partner2026-03-30https://info.adarepharmasolutions.com/resources/an-easy-to-swallow-depression-drug-for-elderly-patientshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Enhancing%20Serialization%20&%20Automation%20to%20Support%20Customer%20Success.pngEnhancing Serialization & Automation to Support Customer SuccessEnhancing Serialization & Automation to Support Customer Successhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Delivering%20a%20Critical%20Therapy%20From%20FDA%20Approval%20to%20Patients%20in%2010%20Days.pngDelivering a Critical Therapy From FDA Approval to Patients in 10 DaysDelivering a Critical Therapy From FDA Approval to Patients in 10 Dayshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Unlocking%20Higher%20Complex%20Capsule%20Yields%20Through%20More%20Efficient%20Manufacturing.pngUnlocking Higher Complex Capsule Yields Through More Efficient ManufacturingUnlocking Higher Complex Capsule Yields Through More Efficient Manufacturinghttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/resources/adare-featured-in-il-sole-24-ore-on-lombardys-economic-importancehttps://info.adarepharmasolutions.com/hubfs/pedoto%20adare%20pharma%20solutions%20lombardia%20strategica%20per%20linternazionalizzazione.mp4/medium.jpgpedoto adare pharma solutions lombardia strategica per linternazionalizzazionepedoto adare pharma solutions lombardia strategica per linternazionalizzazionehttps://info.adarepharmasolutions.com/hubfs/pedoto%20adare%20pharma%20solutions%20lombardia%20strategica%20per%20linternazionalizzazione.mp4378nonohttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partnerhttps://info.adarepharmasolutions.com/hubfs/adare%20interview%20armando.pngadare interview armandoadare interview armandohttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-08-06https://info.adarepharmasolutions.com/resources/navigating-nitrosamine-impurities-with-jason-brownhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-24https://info.adarepharmasolutions.com/newsroom/adare-pharma-solutions-announces-divestiture-of-postbiotics-pioneer-adare-biome-to-dsm-firmenichhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-05-18https://info.adarepharmasolutions.com/resources/supporting-an-innovation-dosing-solution-through-manufacturing-expertisehttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Enhancing%20Serialization%20&%20Automation%20to%20Support%20Customer%20Success.pngEnhancing Serialization & Automation to Support Customer SuccessEnhancing Serialization & Automation to Support Customer Successhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Delivering%20a%20Critical%20Therapy%20From%20FDA%20Approval%20to%20Patients%20in%2010%20Days.pngDelivering a Critical Therapy From FDA Approval to Patients in 10 DaysDelivering a Critical Therapy From FDA Approval to Patients in 10 Dayshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Unlocking%20Higher%20Complex%20Capsule%20Yields%20Through%20More%20Efficient%20Manufacturing.pngUnlocking Higher Complex Capsule Yields Through More Efficient ManufacturingUnlocking Higher Complex Capsule Yields Through More Efficient Manufacturinghttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/resources/type/speaker-presentations2026-04-20https://info.adarepharmasolutions.com/resources/microcapshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Microcaps%C2%AE%20Technology.mp4/medium.jpgMicrocaps® TechnologyMicrocaps® Technologyhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Microcaps%C2%AE%20Technology.mp466nonoTasteSuppressantIngredientBenefitsMicrocapsTechnologyFlavorCapsulesTasteMaskinghttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/resources/key-drug-delivery-news-and-views-from-2024-from-your-partners-c-suitehttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Key%20Drug%20Delivery%20News%20and%20Views%20from%202024%20from%20Your%20Partners%20C-Suite.mp4/medium.jpgKey Drug Delivery News and Views from 2024 from Your Partners' C-SuiteKey Drug Delivery News and Views from 2024 from Your Partners C-Suitehttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Key%20Drug%20Delivery%20News%20and%20Views%20from%202024%20from%20Your%20Partners%20C-Suite.mp42923nonohttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/Key%20Drug%20Delivery%20News%20and%20Views%20from%202024%20from%20Your%20Partners%E2%80%99%20C-Suite.pngKey Drug Delivery News and Views from 2024 from Your Partners’ C-SuiteKey Drug Delivery News and Views from 2024 from Your Partners’ C-Suitehttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/CEO%20Tom%20Sellig%20on%20Important%20Industry%20Challenges.pngCEO Tom Sellig on Important Industry ChallengesCEO Tom Sellig on Important Industry Challengeshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/Endpoints%20Manufacturing%20Day%202025%20%E2%80%93%20CDMO%20Leaders%20Discussion-1.pngEndpoints Manufacturing Day 2025 – CDMO Leaders Discussion-1Endpoints Manufacturing Day 2025 – CDMO Leaders Discussion-1https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/Scaling%203D%20Printing%20and%20Taking%20a%20Global%20Approach%20to%20Supply%20Chain%20Security-1.pngScaling 3D Printing and Taking a Global Approach to Supply Chain Security-1Scaling 3D Printing and Taking a Global Approach to Supply Chain Security-12026-03-30https://info.adarepharmasolutions.com/resources/virtual-tour-teaserhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Virtual%20Tour%20Teaser.mp4/medium.jpgVirtual Tour TeaserVirtual Tour Teaserhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Virtual%20Tour%20Teaser.mp432nonoOfficeSpacesFacilityTourIndustrialLaboratoryhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/resources/long-acting-injectables-strat%C2%B5mhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-24https://info.adarepharmasolutions.com/resources/case-study-from-risk-to-resolution-a-groundbreaking-approach-to-nitrosamine-mitigationhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Delivering%20a%20Critical%20Therapy%20From%20FDA%20Approval%20to%20Patients%20in%2010%20Days.pngDelivering a Critical Therapy From FDA Approval to Patients in 10 DaysDelivering a Critical Therapy From FDA Approval to Patients in 10 Dayshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/From%20Risk%20To%20Resolution_%20A%20Groundbreaking%20Approach%20To%20Nitrosamine%20Mitigation.pngFrom Risk To Resolution_ A Groundbreaking Approach To Nitrosamine MitigationFrom Risk To Resolution_ A Groundbreaking Approach To Nitrosamine Mitigationhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Unlocking%20Higher%20Complex%20Capsule%20Yields%20Through%20More%20Efficient%20Manufacturing.pngUnlocking Higher Complex Capsule Yields Through More Efficient ManufacturingUnlocking Higher Complex Capsule Yields Through More Efficient Manufacturinghttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Enhancing%20Serialization%20&%20Automation%20to%20Support%20Customer%20Success.pngEnhancing Serialization & Automation to Support Customer SuccessEnhancing Serialization & Automation to Support Customer Success2026-03-30https://info.adarepharmasolutions.com/resources/adare-virtual-tour-vandalia-ohhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Adare%20Virtual%20Tour%20%E2%80%93%20Vandalia%2c%20OH.mp4/medium.jpgAdare Virtual Tour – Vandalia, OHAdare Virtual Tour – Vandalia, OHhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Adare%20Virtual%20Tour%20%E2%80%93%20Vandalia%2c%20OH.mp4378nonoManufacturingSiteAdareVirtualTourVandaliaFacilityIndustrialOperationsScientificLaboratoryhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/resources/creating-a-taste-masked-and-easily-swallowed-malaria-drug-for-elderly-patientshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Delivering%20a%20Critical%20Therapy%20From%20FDA%20Approval%20to%20Patients%20in%2010%20Days.pngDelivering a Critical Therapy From FDA Approval to Patients in 10 DaysDelivering a Critical Therapy From FDA Approval to Patients in 10 Dayshttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Unlocking%20Higher%20Complex%20Capsule%20Yields%20Through%20More%20Efficient%20Manufacturing.pngUnlocking Higher Complex Capsule Yields Through More Efficient ManufacturingUnlocking Higher Complex Capsule Yields Through More Efficient Manufacturinghttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Creating%20a%20Taste%20Masked%20and%20Easily%20Swallowed%20Malaria%20Drug%20for%20Elderly%20Patients.pngCreating a Taste Masked and Easily Swallowed Malaria Drug for Elderly PatientsCreating a Taste Masked and Easily Swallowed Malaria Drug for Elderly Patientshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Enhancing%20Serialization%20&%20Automation%20to%20Support%20Customer%20Success.pngEnhancing Serialization & Automation to Support Customer SuccessEnhancing Serialization & Automation to Support Customer Success2026-03-30https://info.adarepharmasolutions.com/resources/drug-development-and-delivery-insights-for-2025https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/New%20Approaches%20to%20Tailored%20Release%20Profiles.mp4/medium.jpgNew Approaches to Tailored Release ProfilesNew Approaches to Tailored Release Profileshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/New%20Approaches%20to%20Tailored%20Release%20Profiles.mp4990nonohttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/New%20Approaches%20to%20Tailored%20Release%20Profiles.pngNew Approaches to Tailored Release ProfilesNew Approaches to Tailored Release Profileshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/Multiparticulates_%20Transforming%20Oral%20Therapies%20Through%20Patient-Centric%20Design.pngMultiparticulates_ Transforming Oral Therapies Through Patient-Centric DesignMultiparticulates_ Transforming Oral Therapies Through Patient-Centric Designhttps://info.adarepharmasolutions.com/hubfs/Webinar%20Your%20Partner%20for%20OSD%20Success%20Thumbnail-1.jpgWebinar Your Partner for OSD Success Thumbnail-1Webinar Your Partner for OSD Success Thumbnail-1https://info.adarepharmasolutions.com/hubfs/Right%20the%20First%20Time%20in%202026%20Modern%20Strategies%20to%20De-Risk%20Complex%20Oral%20Programs%20Under%20Capital%20Pressure%20(1).pngRight the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)Right the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)https://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/resources/podd-sprinkle-on-soft-food-formulations-an-easy-to-swallow-dosage-format-with-dose-flexibilityhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partnerhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Blog%20Thumbnails/PODD-presentation-image.webpPODD-presentation-imagePODD-presentation-image2026-03-24https://info.adarepharmasolutions.com/resources/from-ambiguity-to-action-the-fdas-new-nitrosamine-guidance-2https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/From%20Ambiguity%20To%20Action%20The%20FDA%E2%80%99s%20New%20Nitrosamine%20Guidance.mp4/medium.jpgFrom Ambiguity To Action: The FDA’s New Nitrosamine GuidanceFrom Ambiguity To Action The FDA’s New Nitrosamine Guidancehttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/From%20Ambiguity%20To%20Action%20The%20FDA%E2%80%99s%20New%20Nitrosamine%20Guidance.mp43540nonohttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Webinar%20Your%20Partner%20for%20OSD%20Success%20Thumbnail-1.jpgWebinar Your Partner for OSD Success Thumbnail-1Webinar Your Partner for OSD Success Thumbnail-1https://info.adarepharmasolutions.com/hubfs/Right%20the%20First%20Time%20in%202026%20Modern%20Strategies%20to%20De-Risk%20Complex%20Oral%20Programs%20Under%20Capital%20Pressure%20(1).pngRight the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)Right the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/Multiparticulates_%20Transforming%20Oral%20Therapies%20Through%20Patient-Centric%20Design.pngMultiparticulates_ Transforming Oral Therapies Through Patient-Centric DesignMultiparticulates_ Transforming Oral Therapies Through Patient-Centric Designhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Speaker%20Presentations/Presentation%20From%20Ambiguity%20To%20Action_%20The%20FDA%E2%80%99s%20New%20Nitrosamine%20Guidance.pngPresentation From Ambiguity To Action_ The FDA’s New Nitrosamine GuidancePresentation From Ambiguity To Action_ The FDA’s New Nitrosamine Guidance2026-03-30https://info.adarepharmasolutions.com/resources/overcoming-barriers-to-patient-adherence-with-a-novel-dosage-formhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Unlocking%20Higher%20Complex%20Capsule%20Yields%20Through%20More%20Efficient%20Manufacturing.pngUnlocking Higher Complex Capsule Yields Through More Efficient ManufacturingUnlocking Higher Complex Capsule Yields Through More Efficient Manufacturinghttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Enhancing%20Serialization%20&%20Automation%20to%20Support%20Customer%20Success.pngEnhancing Serialization & Automation to Support Customer SuccessEnhancing Serialization & Automation to Support Customer Successhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Delivering%20a%20Critical%20Therapy%20From%20FDA%20Approval%20to%20Patients%20in%2010%20Days.pngDelivering a Critical Therapy From FDA Approval to Patients in 10 DaysDelivering a Critical Therapy From FDA Approval to Patients in 10 Dayshttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Overcoming%20Barriers%20to%20Patient%20Adherence%20with%20a%20Novel%20Dosage%20Form.pngOvercoming Barriers to Patient Adherence with a Novel Dosage FormOvercoming Barriers to Patient Adherence with a Novel Dosage Form2026-03-30https://info.adarepharmasolutions.com/resources/taste-masking-101-pt1https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Taste%20Masking%20101%20(Session%201%20of%204)%20Optimize%20Taste%20and%20Improve%20Patient%20Treatment%20Outcomes.mp4/medium.jpgTaste Masking 101 (Session 1 of 4): Optimize Taste and Improve Patient Treatment OutcomesTaste Masking 101 (Session 1 of 4) Optimize Taste and Improve Patient Treatment Outcomeshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Taste%20Masking%20101%20(Session%201%20of%204)%20Optimize%20Taste%20and%20Improve%20Patient%20Treatment%20Outcomes.mp43785nonoPatientCentricDrugDesignOralDrugFormulationsPharmaceuticalSolutionsTasteMaskingMedicationAdherencehttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/Taste%20Masking%20101%20(Session%201%20of%204)_%20Optimize%20Taste%20and%20Improve%20Patient%20Treatment%20Outcomes.pngTaste Masking 101 (Session 1 of 4)_ Optimize Taste and Improve Patient Treatment OutcomesTaste Masking 101 (Session 1 of 4)_ Optimize Taste and Improve Patient Treatment Outcomeshttps://info.adarepharmasolutions.com/hubfs/Webinar%20Your%20Partner%20for%20OSD%20Success%20Thumbnail-1.jpgWebinar Your Partner for OSD Success Thumbnail-1Webinar Your Partner for OSD Success Thumbnail-1https://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Right%20the%20First%20Time%20in%202026%20Modern%20Strategies%20to%20De-Risk%20Complex%20Oral%20Programs%20Under%20Capital%20Pressure%20(1).pngRight the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)Right the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/Multiparticulates_%20Transforming%20Oral%20Therapies%20Through%20Patient-Centric%20Design.pngMultiparticulates_ Transforming Oral Therapies Through Patient-Centric DesignMultiparticulates_ Transforming Oral Therapies Through Patient-Centric Design2026-03-30https://info.adarepharmasolutions.com/resources/outsourced-pharma-capacity-update-2024-uli-foley-presentationhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Outsourced%20Pharma%20Capacity%20Update%202024%20-%20Uli%20Foley%20Presentation.mp4/medium.jpgOutsourced Pharma Capacity Update 2024 - Uli Foley PresentationOutsourced Pharma Capacity Update 2024 - Uli Foley Presentationhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Outsourced%20Pharma%20Capacity%20Update%202024%20-%20Uli%20Foley%20Presentation.mp41303nonoNitrosamineMitigationHighlyPotentDrugsPediatricDrugDevelopmentPharmaceuticalManufacturingCDMOCapacityUpdatehttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-24https://info.adarepharmasolutions.com/resources/adare-interactive-overviewhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partnerhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/resources/nitrosamine-reduction-taking-the-genie-out-the-bottlehttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partnerhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/Nitrosamine%20Reduction%20Taking%20the%20Genie%20Out%20the%20Bottle.pngNitrosamine Reduction Taking the Genie Out the BottleNitrosamine Reduction Taking the Genie Out the Bottlehttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/resources/effective-strategies-for-pediatric-formulation-developmenthttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Effective%20Strategies%20For%20Pediatric%20Formulation%20Development.mp4/medium.jpgEffective Strategies For Pediatric Formulation DevelopmentEffective Strategies For Pediatric Formulation Developmenthttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Effective%20Strategies%20For%20Pediatric%20Formulation%20Development.mp43694nonoDosageFormsTasteMaskingPediatricFormulationDevelopmentMedicationAdherencePharmaceuticalTechnologyhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/Effective%20Strategies%20For%20Pediatric%20Formulation%20Development.pngEffective Strategies For Pediatric Formulation DevelopmentEffective Strategies For Pediatric Formulation Developmenthttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Right%20the%20First%20Time%20in%202026%20Modern%20Strategies%20to%20De-Risk%20Complex%20Oral%20Programs%20Under%20Capital%20Pressure%20(1).pngRight the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)Right the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)https://info.adarepharmasolutions.com/hubfs/Webinar%20Your%20Partner%20for%20OSD%20Success%20Thumbnail-1.jpgWebinar Your Partner for OSD Success Thumbnail-1Webinar Your Partner for OSD Success Thumbnail-1https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/Multiparticulates_%20Transforming%20Oral%20Therapies%20Through%20Patient-Centric%20Design.pngMultiparticulates_ Transforming Oral Therapies Through Patient-Centric DesignMultiparticulates_ Transforming Oral Therapies Through Patient-Centric Design2026-03-30https://info.adarepharmasolutions.com/resources/fast-flexible-flawless-manufacturing-in-the-u.s-1https://info.adarepharmasolutions.com/hubfs/Manufacturing%20and%20Regional%20Supply%20Day%20Presentation%20US%20Adare%20-%20Audrey%20Butler%20-%205-6-2026.mp4/medium.jpgManufacturing and Regional Supply Day Presentation US Adare - Audrey Butler - 5-6-2026Manufacturing and Regional Supply Day Presentation US Adare - Audrey Butler - 5-6-2026https://info.adarepharmasolutions.com/hubfs/Manufacturing%20and%20Regional%20Supply%20Day%20Presentation%20US%20Adare%20-%20Audrey%20Butler%20-%205-6-2026.mp4329nonohttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partnerhttps://info.adarepharmasolutions.com/hubfs/Manufacturing%20US%20Webinar-1.pngManufacturing US Webinar-1Manufacturing US Webinar-12026-06-25https://info.adarepharmasolutions.com/newsroom/primary-end-point-achieved-in-phase-iib-study-flute-for-apt-1011https://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-05-18https://info.adarepharmasolutions.com/resources/case-study-meeting-an-aggressive-go-to-clinic-timelinehttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Unlocking%20Higher%20Complex%20Capsule%20Yields%20Through%20More%20Efficient%20Manufacturing.pngUnlocking Higher Complex Capsule Yields Through More Efficient ManufacturingUnlocking Higher Complex Capsule Yields Through More Efficient Manufacturinghttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Enhancing%20Serialization%20&%20Automation%20to%20Support%20Customer%20Success.pngEnhancing Serialization & Automation to Support Customer SuccessEnhancing Serialization & Automation to Support Customer Successhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Delivering%20a%20Critical%20Therapy%20From%20FDA%20Approval%20to%20Patients%20in%2010%20Days.pngDelivering a Critical Therapy From FDA Approval to Patients in 10 DaysDelivering a Critical Therapy From FDA Approval to Patients in 10 Dayshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Meeting%20An%20Aggressive%20Go-To-Clinic%20Timeline.pngMeeting An Aggressive Go-To-Clinic TimelineMeeting An Aggressive Go-To-Clinic Timeline2026-03-30https://info.adarepharmasolutions.com/newsroom/john-fraher-ceo-of-adare-pharmaceuticals-named-ey-entrepreneur-of-the-year-2017-award-winner-in-new-jerseyhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-05-18https://info.adarepharmasolutions.com/resources/type/videos2026-04-20https://info.adarepharmasolutions.com/resources/assessment-of-choking-hazard-of-an-age-appropriate-patient-centric-novel-dosage-form-designed-to-minimize-choking-hazards-in-special-patient-populationshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partnerhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Blog%20Thumbnails/Eupfi.webpEupfiEupfi2026-03-24https://info.adarepharmasolutions.com/resources/advatabhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/AdvaTab%C2%AE%20Technology.mp4/medium.jpgAdvaTab® TechnologyAdvaTab® Technologyhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/AdvaTab%C2%AE%20Technology.mp482nonoTechnicalDetailsHighPerformanceAdvancedOOTProductShowcaseAdvaTabTechnologyhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/resources/combining-patient-centricity-and-commercial-viability-in-pediatric-product-developmenthttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partner2026-03-30https://info.adarepharmasolutions.com/resourceshttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-04-02https://info.adarepharmasolutions.com/newsroom/adare-expands-global-high-potency-handling-packaging-capabilitieshttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-05-18https://info.adarepharmasolutions.com/resources/a-new-framework-for-identifying-nitrosamine-risks-and-efficiently-derisking-productshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partnerhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/resources/managing-poor-solubility-with-cutting-edge-formulation-approacheshttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partner2026-03-30https://info.adarepharmasolutions.com/resources/bbc-adare-videohttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Access%20to%20Choice%20Long%20Acting%20Injectables%20for%20Contraceptives%20(BBC).mp4/medium.jpgAccess to Choice: Long Acting Injectables for Contraceptives (BBC)Access to Choice Long Acting Injectables for Contraceptives (BBC)https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Access%20to%20Choice%20Long%20Acting%20Injectables%20for%20Contraceptives%20(BBC).mp4260nonoBiodegradableMicrospheresWomen'sHealthReproductiveHealthContraceptiveInnovationLongActingInjectableshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Videos/Access%20to%20Choice_%20Long%20Acting%20Injectables%20for%20Contraceptives%20(BBC)-1.pngAccess to Choice_ Long Acting Injectables for Contraceptives (BBC)-1Access to Choice_ Long Acting Injectables for Contraceptives (BBC)-1https://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/newsroom/2024/09/shapiro-administration-invests-in-pas-life-sciences-industry-celebrates-adare-pharma-solutions-relocation-of-global-headquarters-to-philadelphiahttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/PR_PALife_Philly_09202024-scaled-1-2048x1442.webpPR_PALife_Philly_09202024-scaled-1-2048x1442PR_PALife_Philly_09202024-scaled-1-2048x14422026-05-18https://info.adarepharmasolutions.com/newsroom/adare-pharma-solutions-expanding-oral-dose-capabilities-in-europehttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-05-18https://info.adarepharmasolutions.com/newsroom/adare-licenses-cyclobenzaprine-hydrochloride-in-portugalhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-05-18https://info.adarepharmasolutions.com/newsroom/adare-pharma-solutions-appoints-ludger-roedder-as-president-adare-biomehttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-05-18https://info.adarepharmasolutions.com/resources/cphi-north-america-enhancing-acceptance-adherence-in-special-patient-populationshttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Blog%20Thumbnails/CPHI-NA-2024.webpCPHI-NA-2024CPHI-NA-2024https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partner2026-03-24https://info.adarepharmasolutions.com/resources/the-future-of-oral-solids-ebookhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partner2026-04-01https://info.adarepharmasolutions.com/resources/taste-masking-101-pt2https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Taste%20Masking%20101%20(Session%202%20of%204)%20Applications%20and%20Technologies.mp4/medium.jpgTaste Masking 101 (Session 2 of 4): Applications and TechnologiesTaste Masking 101 (Session 2 of 4) Applications and Technologieshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Taste%20Masking%20101%20(Session%202%20of%204)%20Applications%20and%20Technologies.mp43677nonoDrugAcceptabilityPatientCentricDesignTasteMaskingMedicationAdherencePharmaceuticalTechnologieshttps://info.adarepharmasolutions.com/hubfs/Webinar%20Your%20Partner%20for%20OSD%20Success%20Thumbnail-1.jpgWebinar Your Partner for OSD Success Thumbnail-1Webinar Your Partner for OSD Success Thumbnail-1https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/Taste%20Masking%20101%20(Session%202%20of%204)_%20Applications%20and%20Technologies.pngTaste Masking 101 (Session 2 of 4)_ Applications and TechnologiesTaste Masking 101 (Session 2 of 4)_ Applications and Technologieshttps://info.adarepharmasolutions.com/hubfs/Right%20the%20First%20Time%20in%202026%20Modern%20Strategies%20to%20De-Risk%20Complex%20Oral%20Programs%20Under%20Capital%20Pressure%20(1).pngRight the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)Right the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/Multiparticulates_%20Transforming%20Oral%20Therapies%20Through%20Patient-Centric%20Design.pngMultiparticulates_ Transforming Oral Therapies Through Patient-Centric DesignMultiparticulates_ Transforming Oral Therapies Through Patient-Centric Designhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/newsroom/adare-pharma-solutions-opens-new-small-scale-laboratory-to-offer-faster-and-more-efficient-development-capabilities-to-clientshttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-05-18https://info.adarepharmasolutions.com/resources/outsourced-pharma-march-2022https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Integrated%20Solutions%20From%20Start%20to%20Finish%20Outsourced%20Pharma%20March%202022.mp4/medium.jpgIntegrated Solutions From Start to Finish: Outsourced Pharma March 2022Integrated Solutions From Start to Finish Outsourced Pharma March 2022https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Integrated%20Solutions%20From%20Start%20to%20Finish%20Outsourced%20Pharma%20March%202022.mp41415nonoDrugDevelopmentCDMOServicesOutsourcedPharmaPharmaceuticalManufacturingGoodManufacturingPracticeshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/Integrated%20Solutions%20From%20Start%20to%20Finish_%20Outsourced%20Pharma%20March%202022.pngIntegrated Solutions From Start to Finish_ Outsourced Pharma March 2022Integrated Solutions From Start to Finish_ Outsourced Pharma March 2022https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/Multiparticulates_%20Transforming%20Oral%20Therapies%20Through%20Patient-Centric%20Design.pngMultiparticulates_ Transforming Oral Therapies Through Patient-Centric DesignMultiparticulates_ Transforming Oral Therapies Through Patient-Centric Designhttps://info.adarepharmasolutions.com/hubfs/Right%20the%20First%20Time%20in%202026%20Modern%20Strategies%20to%20De-Risk%20Complex%20Oral%20Programs%20Under%20Capital%20Pressure%20(1).pngRight the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)Right the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)https://info.adarepharmasolutions.com/hubfs/Webinar%20Your%20Partner%20for%20OSD%20Success%20Thumbnail-1.jpgWebinar Your Partner for OSD Success Thumbnail-1Webinar Your Partner for OSD Success Thumbnail-1https://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/resources/enhancing-acceptance-and-adherence-in-special-patient-populationshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/CPHI%20North%20America%20%E2%80%93%20Enhancing%20Acceptance%20&%20Adherence%20in%20Special%20Patient%20Populations.mp4/medium.jpgCPHI North America – Enhancing Acceptance & Adherence in Special Patient PopulationsCPHI North America – Enhancing Acceptance & Adherence in Special Patient Populationshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/CPHI%20North%20America%20%E2%80%93%20Enhancing%20Acceptance%20&%20Adherence%20in%20Special%20Patient%20Populations.mp42222nonoPharmaceuticalSolutionsDoseFlexibilitySpecialPopulationsAdherenceStrategiesPatientCentricityhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partner2026-03-24https://info.adarepharmasolutions.com/newsroom/adare-pharmaceuticals-celebrates-corporate-headquarters-grand-openinghttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-05-18https://info.adarepharmasolutions.com/resources/drug-development-delivery-tom-sellig-executive-interviewhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/Endpoints%20Manufacturing%20Day%202025%20%E2%80%93%20CDMO%20Leaders%20Discussion-1.pngEndpoints Manufacturing Day 2025 – CDMO Leaders Discussion-1Endpoints Manufacturing Day 2025 – CDMO Leaders Discussion-1https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/Drug%20Development%20&%20Delivery%20%E2%80%93%20Tom%20Sellig%20Executive%20Interview.pngDrug Development & Delivery – Tom Sellig Executive InterviewDrug Development & Delivery – Tom Sellig Executive Interviewhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Blog%20Thumbnails/Drug%20Development%20&%20Delivery%20%E2%80%93%20Tom%20Sellig%20Executive%20Interview%20thumbnail.pngDrug Development & Delivery – Tom Sellig Executive Interview thumbnailDrug Development & Delivery – Tom Sellig Executive Interview thumbnailhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/Scaling%203D%20Printing%20and%20Taking%20a%20Global%20Approach%20to%20Supply%20Chain%20Security-1.pngScaling 3D Printing and Taking a Global Approach to Supply Chain Security-1Scaling 3D Printing and Taking a Global Approach to Supply Chain Security-1https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/CEO%20Tom%20Sellig%20on%20Important%20Industry%20Challenges.pngCEO Tom Sellig on Important Industry ChallengesCEO Tom Sellig on Important Industry Challenges2026-03-30https://info.adarepharmasolutions.com/resources/ceo-of-adare-pharma-tom-sellig-articulating-core-values-during-a-high-stakes-interviewhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Blog%20Thumbnails/CEO%20of%20Adare%20Pharma%20Tom%20Sellig%20Articulating%20Core%20Values.webpCEO of Adare Pharma Tom Sellig Articulating Core ValuesCEO of Adare Pharma Tom Sellig Articulating Core Valueshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/CEO%20of%20Adare%20Pharma%20Tom%20Sellig%20Articulating%20Core%20Values.pngCEO of Adare Pharma Tom Sellig Articulating Core ValuesCEO of Adare Pharma Tom Sellig Articulating Core Valueshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/Scaling%203D%20Printing%20and%20Taking%20a%20Global%20Approach%20to%20Supply%20Chain%20Security-1.pngScaling 3D Printing and Taking a Global Approach to Supply Chain Security-1Scaling 3D Printing and Taking a Global Approach to Supply Chain Security-1https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/Endpoints%20Manufacturing%20Day%202025%20%E2%80%93%20CDMO%20Leaders%20Discussion-1.pngEndpoints Manufacturing Day 2025 – CDMO Leaders Discussion-1Endpoints Manufacturing Day 2025 – CDMO Leaders Discussion-1https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/CEO%20Tom%20Sellig%20on%20Important%20Industry%20Challenges.pngCEO Tom Sellig on Important Industry ChallengesCEO Tom Sellig on Important Industry Challengeshttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/resources/scaling-3d-printing-and-taking-a-global-approach-to-supply-chain-securityhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/Scaling%203D%20Printing%20and%20Taking%20a%20Global%20Approach%20to%20Supply%20Chain%20Security-1.pngScaling 3D Printing and Taking a Global Approach to Supply Chain Security-1Scaling 3D Printing and Taking a Global Approach to Supply Chain Security-1https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/CEO%20Tom%20Sellig%20on%20Important%20Industry%20Challenges.pngCEO Tom Sellig on Important Industry ChallengesCEO Tom Sellig on Important Industry Challengeshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/Fast%2c%20Flexible%2c%20Focused_%20The%20Secrets%20of%20a%20Successful%20CDMO%20Partnership.pngFast, Flexible, Focused_ The Secrets of a Successful CDMO PartnershipFast, Flexible, Focused_ The Secrets of a Successful CDMO Partnershiphttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/Endpoints%20Manufacturing%20Day%202025%20%E2%80%93%20CDMO%20Leaders%20Discussion-1.pngEndpoints Manufacturing Day 2025 – CDMO Leaders Discussion-1Endpoints Manufacturing Day 2025 – CDMO Leaders Discussion-1https://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/resources/oral-solid-dose-manufacturing-for-pediatrics-and-other-special-patient-populationshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Oral%20Solid%20Dose%20Manufacturing%20For%20Pediatrics%20And%20Other%20Special%20Patient%20Populations.mp4/medium.jpgOral Solid Dose Manufacturing For Pediatrics And Other Special Patient PopulationsOral Solid Dose Manufacturing For Pediatrics And Other Special Patient Populationshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Oral%20Solid%20Dose%20Manufacturing%20For%20Pediatrics%20And%20Other%20Special%20Patient%20Populations.mp4702nonoManufacturingForPediatricsTasteMaskingTechnologiesOralSolidDosePatientCentricFormulationsCDMOSolutionshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/Oral%20Solid%20Dose%20Manufacturing%20For%20Pediatrics%20And%20Other%20Special%20Patient%20Populations.pngOral Solid Dose Manufacturing For Pediatrics And Other Special Patient PopulationsOral Solid Dose Manufacturing For Pediatrics And Other Special Patient Populationshttps://info.adarepharmasolutions.com/hubfs/Right%20the%20First%20Time%20in%202026%20Modern%20Strategies%20to%20De-Risk%20Complex%20Oral%20Programs%20Under%20Capital%20Pressure%20(1).pngRight the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)Right the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)https://info.adarepharmasolutions.com/hubfs/Webinar%20Your%20Partner%20for%20OSD%20Success%20Thumbnail-1.jpgWebinar Your Partner for OSD Success Thumbnail-1Webinar Your Partner for OSD Success Thumbnail-1https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/Multiparticulates_%20Transforming%20Oral%20Therapies%20Through%20Patient-Centric%20Design.pngMultiparticulates_ Transforming Oral Therapies Through Patient-Centric DesignMultiparticulates_ Transforming Oral Therapies Through Patient-Centric Designhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/resources/enhancing-serialization-automation-to-support-customer-successhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Enhancing%20Serialization%20&%20Automation%20to%20Support%20Customer%20Success.pngEnhancing Serialization & Automation to Support Customer SuccessEnhancing Serialization & Automation to Support Customer Successhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Unlocking%20Higher%20Complex%20Capsule%20Yields%20Through%20More%20Efficient%20Manufacturing.pngUnlocking Higher Complex Capsule Yields Through More Efficient ManufacturingUnlocking Higher Complex Capsule Yields Through More Efficient Manufacturinghttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Delivering%20a%20Critical%20Therapy%20From%20FDA%20Approval%20to%20Patients%20in%2010%20Days.pngDelivering a Critical Therapy From FDA Approval to Patients in 10 DaysDelivering a Critical Therapy From FDA Approval to Patients in 10 Days2026-03-30https://info.adarepharmasolutions.com/resources/taste-masking-101-a-qa-with-the-expertshttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partner2026-03-30https://info.adarepharmasolutions.com/resources/3d-screen-printing-enabling-a-new-generation-of-complex-formulationshttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partner2026-03-30https://info.adarepharmasolutions.com/resources/your-partner-for-oral-solid-dose-successhttps://info.adarepharmasolutions.com/hubfs/OPCU%20Your%20Partner%20For%20Oral%20Solid%20Dose%20Success%20-%20Drew%20Bradley%20-%204-21-2026.mp4/medium.jpgOutsourced Pharma Capacity Update 2026 - Your Partner For Oral Solid Dose SuccessAre you searching for a reliable partner to accelerate your pharmaceutical development? In this insightful presentation, Drew Bradley, Vice President of Business Development at Adare Pharma Solutions, outlines how Adare's technology-driven CDMO services can enhance your drug development journey.https://info.adarepharmasolutions.com/hubfs/OPCU%20Your%20Partner%20For%20Oral%20Solid%20Dose%20Success%20-%20Drew%20Bradley%20-%204-21-2026.mp4572nonoAdarePharmaSolutionsDrugManufacturingTechnologyDrivenCDMOPharmaceuticalDevelopmentOralSolidDosehttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Webinar%20Your%20Partner%20for%20OSD%20Success%20Thumbnail-1.jpgWebinar Your Partner for OSD Success Thumbnail-1Webinar Your Partner for OSD Success Thumbnail-1https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/The%20Future%20of%20Pharma%20Packaging_%20Trends%2c%20Technologies%2c%20and%20Patient-Centric%20Solutions.pngThe Future of Pharma Packaging_ Trends, Technologies, and Patient-Centric SolutionsThe Future of Pharma Packaging_ Trends, Technologies, and Patient-Centric Solutionshttps://info.adarepharmasolutions.com/hubfs/Right%20the%20First%20Time%20in%202026%20Modern%20Strategies%20to%20De-Risk%20Complex%20Oral%20Programs%20Under%20Capital%20Pressure%20(1).pngRight the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)Right the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/Multiparticulates_%20Transforming%20Oral%20Therapies%20Through%20Patient-Centric%20Design.pngMultiparticulates_ Transforming Oral Therapies Through Patient-Centric DesignMultiparticulates_ Transforming Oral Therapies Through Patient-Centric Design2026-06-01https://info.adarepharmasolutions.com/resources/pharmaceutical-outsourcing-a-solid-dosage-futurehttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Pharmaceutical%20Outsourcing%20A%20Solid%20Dosage%20Future.mp4/medium.jpgPharmaceutical Outsourcing: A Solid Dosage FuturePharmaceutical Outsourcing A Solid Dosage Futurehttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Pharmaceutical%20Outsourcing%20A%20Solid%20Dosage%20Future.mp41520nonoBioavailabilityChallengesContinuousManufacturingPharmaceuticalOutsourcingPatientCentricitySolidDosageFormshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Blog%20Thumbnails/Pharmaceutical%20Outsourcing_%20A%20Solid%20Dosage%20Future.pngPharmaceutical Outsourcing_ A Solid Dosage FuturePharmaceutical Outsourcing_ A Solid Dosage Futurehttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/resources/path-towards-efficient-pediatric-formulation-developmenthttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partnerhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/Path%20Towards%20Efficient%20Pediatric%20Formulation%20Development.pngPath Towards Efficient Pediatric Formulation DevelopmentPath Towards Efficient Pediatric Formulation Development2026-03-30https://info.adarepharmasolutions.com/resources/type/articles2026-04-20https://info.adarepharmasolutions.com/newsroom/2025/10/adare-pharma-solutions-completes-packaging-warehousing-expansion-in-europehttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-05-18https://info.adarepharmasolutions.com/resources/global-business-report-interviews-ceo-tom-sellighttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/Global%20Business%20Report%20Interviews%20CEO%20Tom%20Sellig-1.pngGlobal Business Report Interviews CEO Tom Sellig-1Global Business Report Interviews CEO Tom Sellig-1https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/Scaling%203D%20Printing%20and%20Taking%20a%20Global%20Approach%20to%20Supply%20Chain%20Security-1.pngScaling 3D Printing and Taking a Global Approach to Supply Chain Security-1Scaling 3D Printing and Taking a Global Approach to Supply Chain Security-1https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/CEO%20Tom%20Sellig%20on%20Important%20Industry%20Challenges.pngCEO Tom Sellig on Important Industry ChallengesCEO Tom Sellig on Important Industry Challengeshttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/Endpoints%20Manufacturing%20Day%202025%20%E2%80%93%20CDMO%20Leaders%20Discussion-1.pngEndpoints Manufacturing Day 2025 – CDMO Leaders Discussion-1Endpoints Manufacturing Day 2025 – CDMO Leaders Discussion-1https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Blog%20Thumbnails/Global%20Business%20Report%20Interviews%20CEO%20Tom%20Sellig-1.pngGlobal Business Report Interviews CEO Tom Sellig-1Global Business Report Interviews CEO Tom Sellig-12026-03-30https://info.adarepharmasolutions.com/resources/adare-cphi-milan-2024https://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/Endpoints%20Manufacturing%20Day%202025%20%E2%80%93%20CDMO%20Leaders%20Discussion-1.pngEndpoints Manufacturing Day 2025 – CDMO Leaders Discussion-1Endpoints Manufacturing Day 2025 – CDMO Leaders Discussion-1https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/CPHI%20Milan%202024_%20Interview%20with%20Adare%20CEO%20Tom%20Sellig.pngCPHI Milan 2024_ Interview with Adare CEO Tom SelligCPHI Milan 2024_ Interview with Adare CEO Tom Sellighttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/Scaling%203D%20Printing%20and%20Taking%20a%20Global%20Approach%20to%20Supply%20Chain%20Security-1.pngScaling 3D Printing and Taking a Global Approach to Supply Chain Security-1Scaling 3D Printing and Taking a Global Approach to Supply Chain Security-1https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Leadership%20Interviews/CEO%20Tom%20Sellig%20on%20Important%20Industry%20Challenges.pngCEO Tom Sellig on Important Industry ChallengesCEO Tom Sellig on Important Industry Challenges2026-03-24https://info.adarepharmasolutions.com/newsroom/adare-pharmaceuticals-appoints-james-jogerst-as-vice-president-corporate-developmenthttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-05-18https://info.adarepharmasolutions.com/resources/adare-pa-governors-press-conferencehttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Adare%20PA%20Governor%20Press%20Conference.mp4/medium.jpgAdare PA Governor Press ConferenceAdare PA Governor Press Conferencehttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Adare%20PA%20Governor%20Press%20Conference.mp42436nonoAdarePharmaSolutionsBusinessPartnershipsPennsylvaniaBusinessRelocationEconomicDevelopmentLifeSciencesInnovationhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/resources/type/case-studies2026-04-20https://info.adarepharmasolutions.com/resources/taste-masking-solutions-for-pediatric-populationshttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partner2026-03-24https://info.adarepharmasolutions.com/resources/when-tablets-go-digital-how-3d-printing-is-breaking-the-rules-of-pharma-manufacturinghttps://info.adarepharmasolutions.com/hubfs/Adare_Contract_Pharma_3D%20Screen%20Printing%20Webinar_7_22_26.mp4/medium.jpgAdare_Contract_Pharma_3D Screen Printing Webinar_7_22_26Adare_Contract_Pharma_3D Screen Printing Webinar_7_22_26https://info.adarepharmasolutions.com/hubfs/Adare_Contract_Pharma_3D%20Screen%20Printing%20Webinar_7_22_26.mp43769nonohttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center%20-%20When%20Tablets%20Go%20Digital.pngResource Center - When Tablets Go DigitalResource Center - When Tablets Go Digitalhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partner2026-07-31https://info.adarepharmasolutions.com/resources/taste-masked-dosage-form-for-pediatric-oral-delivery-an-industrial-perspectivehttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partnerhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-24https://info.adarepharmasolutions.com/resources/maintaining-a-drugs-bioavailability-and-masking-taste-with-microencapsulationhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partnerhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/resources/delivering-a-critical-therapy-from-fda-approval-to-patients-in-10-dayshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Unlocking%20Higher%20Complex%20Capsule%20Yields%20Through%20More%20Efficient%20Manufacturing.pngUnlocking Higher Complex Capsule Yields Through More Efficient ManufacturingUnlocking Higher Complex Capsule Yields Through More Efficient Manufacturinghttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Enhancing%20Serialization%20&%20Automation%20to%20Support%20Customer%20Success.pngEnhancing Serialization & Automation to Support Customer SuccessEnhancing Serialization & Automation to Support Customer Successhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Delivering%20a%20Critical%20Therapy%20From%20FDA%20Approval%20to%20Patients%20in%2010%20Days.pngDelivering a Critical Therapy From FDA Approval to Patients in 10 DaysDelivering a Critical Therapy From FDA Approval to Patients in 10 Days2026-03-30https://info.adarepharmasolutions.com/resources/diffucapshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Diffucaps%C2%AE%20Technology.mp4/medium.jpgDiffucaps® TechnologyDiffucaps® Technologyhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Diffucaps%C2%AE%20Technology.mp475nonoAdarePharmaceuticalsDiffucapsDrugDeliveryCustomizedReleaseMedicalApplicationshttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/resources/formulation-of-aqueous-core-polylactic-acid-microcapsules-ndormer-scientific-briefinghttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partner2026-03-30https://info.adarepharmasolutions.com/resources/unlocking-higher-complex-capsule-yields-through-more-efficient-manufacturinghttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Unlocking%20Higher%20Complex%20Capsule%20Yields%20Through%20More%20Efficient%20Manufacturing.pngUnlocking Higher Complex Capsule Yields Through More Efficient ManufacturingUnlocking Higher Complex Capsule Yields Through More Efficient Manufacturinghttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Enhancing%20Serialization%20&%20Automation%20to%20Support%20Customer%20Success.pngEnhancing Serialization & Automation to Support Customer SuccessEnhancing Serialization & Automation to Support Customer Successhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Case%20Studies/Delivering%20a%20Critical%20Therapy%20From%20FDA%20Approval%20to%20Patients%20in%2010%20Days.pngDelivering a Critical Therapy From FDA Approval to Patients in 10 DaysDelivering a Critical Therapy From FDA Approval to Patients in 10 Days2026-03-30https://info.adarepharmasolutions.com/resources/taste-masking-101-session-4-sensory-and-performance-evaluationhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Taste%20Masking%20101%20(Session%204%20of%204)%20Sensory%20and%20Performance%20Evaluation.mp4/medium.jpgTaste Masking 101 (Session 4 of 4) Sensory and Performance EvaluationTaste Masking 101 (Session 4 of 4) Sensory and Performance Evaluationhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Taste%20Masking%20101%20(Session%204%20of%204)%20Sensory%20and%20Performance%20Evaluation.mp43636nonoSensoryScienceETongueTechnologyNeuroscienceMethodsTasteEvaluationTasteMaskinghttps://info.adarepharmasolutions.com/hubfs/Webinar%20Your%20Partner%20for%20OSD%20Success%20Thumbnail-1.jpgWebinar Your Partner for OSD Success Thumbnail-1Webinar Your Partner for OSD Success Thumbnail-1https://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/Multiparticulates_%20Transforming%20Oral%20Therapies%20Through%20Patient-Centric%20Design.pngMultiparticulates_ Transforming Oral Therapies Through Patient-Centric DesignMultiparticulates_ Transforming Oral Therapies Through Patient-Centric Designhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Webinars/Taste%20Masking%20101%20(Session%204%20of%204)_%20Sensory%20and%20Performance%20Evaluation.pngTaste Masking 101 (Session 4 of 4)_ Sensory and Performance EvaluationTaste Masking 101 (Session 4 of 4)_ Sensory and Performance Evaluationhttps://info.adarepharmasolutions.com/hubfs/Right%20the%20First%20Time%20in%202026%20Modern%20Strategies%20to%20De-Risk%20Complex%20Oral%20Programs%20Under%20Capital%20Pressure%20(1).pngRight the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)Right the First Time in 2026 Modern Strategies to De-Risk Complex Oral Programs Under Capital Pressure (1)2026-03-30https://info.adarepharmasolutions.com/resources/controlled-release-society-harmonizing-medication-delivery-with-the-bodys-natural-rhythmshttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partnerhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-24https://info.adarepharmasolutions.com/resources/a-guide-to-oral-solid-dose-manufacturing-success-ebookhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partner2026-03-30https://info.adarepharmasolutions.com/resources/nitrosamine-mitigation-a-path-to-regulatory-compliancehttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-colorhttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Articles/From%20Service%20Provider%20to%20Strategic%20Partner.jpgFrom Service Provider to Strategic PartnerFrom Service Provider to Strategic Partner2026-03-30https://info.adarepharmasolutions.com/newsroom/shapiro-administration-invests-nearly-3-million-to-bring-adare-pharma-solutions-headquarters-to-pennsylvania-creating-115-new-well-paying-jobs-in-philadelphiahttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-05-18https://info.adarepharmasolutions.com/resources/adare-corporate-videohttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Adare%20Corporate%20Video.mp4/medium.jpgAdare Corporate VideoAdare Corporate Videohttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Adare%20Corporate%20Video.mp4206nonoAdarePharmaSolutionsDrugDeliveryImprovingLivesEndToEndServicesPharmaceuticalTechnologyhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30https://info.adarepharmasolutions.com/resources/giant-a86-blister-packaging-linehttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Giant-A86%20Blister%20Packaging%20Line.mp4/medium.jpgGiant-A86 Blister Packaging LineGiant-A86 Blister Packaging Linehttps://info.adarepharmasolutions.com/hubfs/Resource%20Center/Videos/Giant-A86%20Blister%20Packaging%20Line.mp449nonoIndustrialAutomationGiantA86HighVolumeProductionBlisterPackagingPackagingMachineryhttps://info.adarepharmasolutions.com/hubfs/921b4f2a84b673c206f0b35e0c7f6cc5.logo-color.svgAdare Logo921b4f2a84b673c206f0b35e0c7f6cc5.logo-color2026-03-30